Anticoagulants Concept

subject area of

• "2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19": reply.  Journal Articles
• "Therapeutic range" for oral anticoagulant therapy.  Journal Articles
• 10 Anticoagulant therapy in venous thromboembolism  Journal Articles
• 14 Antithrombotic treatment of cerebrovascular disease  Journal Articles
• 15 Side-effects of antithrombotic therapy  Journal Articles
• 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1  Journal Articles
• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants  Journal Articles
• 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis  Journal Articles
• 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer  Journal Articles
• 2019 international clinical practice guidelines for the treatment of venous thromboembolism – Authors' reply  Journal Articles
• 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants  Journal Articles
• 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)  Journal Articles
• 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19  Journal Articles
• 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19  Journal Articles
• 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE  Journal Articles
• 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII  Journal Articles
• ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia  Journal Articles
• In‐Vitro Studies with Ancrod (‘Arvin’)  Journal Articles
• Reviews: Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis  Journal Articles
• d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism  Journal Articles
• d-Dimer Testing to Determine the Duration of Anticoagulation Therapy  Journal Articles
• d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy  Journal Articles
• A 14-year study of heparin-induced thrombocytopenia  Journal Articles
• A 75-Year-Old Man With Congestive Heart Failure  Journal Articles
• A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery  Journal Articles
• A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation  Journal Articles
• A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients  Journal Articles
• A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis  Journal Articles
• A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism  Journal Articles
• A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism  Journal Articles
• A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome  Journal Articles
• A Comparison of the Safety and Efficacy of Oral Antiocoagulation for the Treatment of Venous Thromboembolic Disease in Patients with or without Malignancy  Journal Articles
• A Computer Generated Induction System for Hospitalized Patients Starting on Oral Anticoagulant Therapy  Journal Articles
• A Device on Trial — Intermittent Pneumatic Compression in Critical Care  Journal Articles
• A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures  Journal Articles
• A Historical Perspective on the Reversal of Anticoagulants  Journal Articles
• A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism  Journal Articles
• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction  Journal Articles
• A National Survey of Canadian Practice Patterns of Warfarin After Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy  Journal Articles
• A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era  Journal Articles
• A Novel Whole Blood Capillary Technic for Measuring the Prothrombin Time  Journal Articles
• A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial  Journal Articles
• A Pilot Study on the Randomization of Inferior Vena Cava Filter Placement for Venous Thromboembolism Prophylaxis in High-Risk Trauma Patients  Journal Articles
• A PoTENtial Antidote  Journal Articles
• A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin  Journal Articles
• A Protease TAMER: a nucleic acid‐based anticoagulant  Journal Articles
• A Randomized Comparison of a Computer-Based Dosing Program with a Manual System to Monitor Oral Anticoagulant Therapy  Journal Articles
• A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses  Journal Articles
• A Replacement for Warfarin  Journal Articles
• A Step Change in Oral Anticoagulation: Lack of Coagulation Monitoring with Ximelagatran  Journal Articles
• A Survey of the Use of Empiric Novel Anticoagulants During Investigation of Stroke  Journal Articles
• A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis  Journal Articles
• A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement  Journal Articles
• A Systematic Review of Heparin to Treat Burn Injury  Journal Articles
• A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score  Journal Articles
• A clinical conundrum: to measure or not measure direct oral anticoagulants before a surgery or procedure?  Journal Articles
• A comparative study of platelet factor 4‐enhanced platelet activation assays for the diagnosis of heparin‐induced thrombocytopenia  Journal Articles
• A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)  Journal Articles
• A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system  Journal Articles
• A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty  Journal Articles
• A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation  Journal Articles
• A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery  Journal Articles
• A fulminant neurologic presentation of systemic lupus erythematosus  Journal Articles
• A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.  Journal Articles
• A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation  Journal Articles
• A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients  Journal Articles
• A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program  Journal Articles
• A multicentre randomised clinical endpoint study of parma 5 computer‐assisted oral anticoagulant dosage  Journal Articles
• A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist.  Journal Articles
• A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury  Journal Articles
• A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment  Journal Articles
• A novel antithrombin-heparin covalent complex  Journal Articles
• A novel antithrombotic coronary stent: lysine-poly(HEMA)-modified cobalt–chromium stent with fibrinolytic activity  Journal Articles
• A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers  Journal Articles
• A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin  Journal Articles
• A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study  Journal Articles
• A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery  Journal Articles
• A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin  Journal Articles
• A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design  Journal Articles
• A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions  Journal Articles
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin  Journal Articles
• A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I  Journal Articles
• A review of heart failure treatment.  Journal Articles
• A review of the oral direct thrombin inhibitor ximelagatran  Journal Articles
• A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction  Journal Articles
• A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation  Journal Articles
• A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal  Journal Articles
• A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism  Journal Articles
• AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIa  Journal Articles
• ABC of antithrombotic therapy: Valvar heart disease and prosthetic heart valves  Journal Articles
• ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies  Journal Articles
• ANTICOAGULANTS AND OTHER DRUGS IN THROMBOSIS  Journal Articles
• ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery  Journal Articles
• ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?  Journal Articles
• ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America  Journal Articles
• Abelacimab for Prevention of Venous Thromboembolism  Journal Articles
• Abelacimab for Prevention of Venous Thromboembolism  Journal Articles
• Accumulating data on rivaroxaban for venous thromboembolism in clinical practice  Journal Articles
• Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy  Journal Articles
• Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals  Journal Articles
• Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors  Journal Articles
• Activated protein C in sepsis and beyond: Update 2006  Journal Articles
• Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia  Journal Articles
• Acute coronary syndromes: a focus on thrombin.  Journal Articles
• Acute intraoperative HIT during heart surgery: Why so rare?  Journal Articles
• Acute management of bleeding in patients on novel oral anticoagulants  Journal Articles
• Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants  Journal Articles
• Acute reversal of anticoagulant-induced bleeding complications.  Journal Articles
• Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria  Journal Articles
• Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012  Journal Articles
• Addressing the burden of hospital‐related venous thromboembolism: the role of extended anticoagulant prophylaxis  Journal Articles
• Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study  Journal Articles
• Adjunctive therapy for myocardial infarction.  Journal Articles
• Advances and Contemporary Issues in Prophylaxis for Deep Vein Thrombosis  Journal Articles
• Advances and contemporary issues in prophylaxis for deep vein thrombosis.  Journal Articles
• Advances in Thrombosis and Hemostasis  Journal Articles
• Advances in anticoagulation: patients with bioprosthetic heart valves  Journal Articles
• Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents  Journal Articles
• Advances in the management of venous thromboembolism  Journal Articles
• Advances in the management of venous thromboembolism.  Journal Articles
• Advantages and limitations of the new anticoagulants  Journal Articles
• Adverse Prognostic Significance of Thrombocytopenia in Acute Coronary Syndrome  Journal Articles
• Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study  Journal Articles
• Adverse outcomes associated with managing suspected heparin induced thrombocytopenia in the critically ill  Journal Articles
• After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding  Journal Articles
• Agents for the Treatment of Heparin-Induced Thrombocytopenia  Journal Articles
• Airways Disease Presenting as Restrictive Impairment: Response  Journal Articles
• Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation  Journal Articles
• Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper  Journal Articles
• Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  Journal Articles
• Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study  Journal Articles
• American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty Differ  Journal Articles
• American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period  Journal Articles
• American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy  Journal Articles
• American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.  Journal Articles
• American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer  Journal Articles
• American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy  Journal Articles
• American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer  Journal Articles
• American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19  Journal Articles
• American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing  Journal Articles
• American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients  Journal Articles
• American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients  Journal Articles
• American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis  Journal Articles
• American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients  Journal Articles
• An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients  Journal Articles
• An Instrument-based Immunoassay with an Appropriate Normal Range: Minimizing HIT Overdiagnosis  Journal Articles
• An International Survey on the Use of Thromboprophylaxis in Urological Surgery  Journal Articles
• An Overview of the Heparin-Induced Thrombocytopenia Syndrome  Journal Articles
• An Update on New Anticoagulants  Journal Articles
• An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.  Journal Articles
• An international external quality assessment for laboratory diagnosis of heparin‐induced thrombocytopenia  Journal Articles
• An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage  Journal Articles
• An opinion on the benefits of concomitant oral contraceptive therapy in premenopausal women treated with oral anticoagulants  Journal Articles
• An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta‐analysis  Journal Articles
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Journal Articles
• Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients  Journal Articles
• Analysis of a nonsusceptible fraction with current status data  Journal Articles
• Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study  Journal Articles
• Ancrod (Arvin®) as an Alternative to Heparin Anticoagulation for Cardiopulmonary Bypass  Journal Articles
• Andexanet alfa for the treatment of hemorrhage  Journal Articles
• Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis  Journal Articles
• Animal Models of Thrombosis From Zebrafish to Nonhuman Primates  Journal Articles
• Another oral thrombin inhibitor for stroke prevention in atrial fibrillation?  Journal Articles
• Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial  Journal Articles
• Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients  Journal Articles
• Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy  Journal Articles
• Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.  Journal Articles
• Anticoagulant Actions of Tissue Factor Pathway Inhibitor on Tissue-Factor-Dependent Plasma Coagulation  Journal Articles
• Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review  Journal Articles
• Anticoagulant Treatment of COVID-19 as Early as Possible—Sulodexide and Perspectives  Journal Articles
• Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls  Journal Articles
• Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography  Journal Articles
• Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency  Journal Articles
• Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis  Journal Articles
• Anticoagulant response after dalteparin overdose  Journal Articles
• Anticoagulant therapy following acute myocardial infarction. Part I. Incidence of and factors predisposing to thromboembolism associated with acute myocardial infarction.  Journal Articles
• Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?  Journal Articles
• Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis  Journal Articles
• Anticoagulant therapy for splanchnic vein thrombosis  Journal Articles
• Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis  Journal Articles
• Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome  Conferences
• Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents  Journal Articles
• Anticoagulant-Related Nephropathy  Journal Articles
• Anticoagulants and Gastrointestinal Bleeding  Journal Articles
• Anticoagulants and Their Reversal  Journal Articles
• Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease  Journal Articles
• Anticoagulants in Venous Thromboembolism  Journal Articles
• Anticoagulants in acute coronary syndromes  Journal Articles
• Anticoagulants in atrial fibrillation patients with chronic kidney disease  Journal Articles
• Anticoagulants in heart disease: current status and perspectives  Journal Articles
• Anticoagulants in pediatric cerebral sinovenous thrombosis: A safety and outcome study  Journal Articles
• Anticoagulants in pregnancy: A review of indications and complications  Journal Articles
• Anticoagulation Control with Daily Low‐Dose Vitamin K to Reduce Clinically Adverse Outcomes and International Normalized Ratio Variability: A Systematic Review and Meta‐Analysis  Journal Articles
• Anticoagulation Therapy  Journal Articles
• Anticoagulation Therapy in Children  Journal Articles
• Anticoagulation Therapy in Children  Journal Articles
• Anticoagulation Therapy in Pediatric Patients With Sinovenous Thrombosis  Journal Articles
• Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group  Journal Articles
• Anticoagulation and in vitro fertilization and ovarian stimulation  Journal Articles
• Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target  Journal Articles
• Anticoagulation for Mechanical Heart Valves  Journal Articles
• Anticoagulation for ST-Segment Elevation Myocardial Infarction  Journal Articles
• Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease—First, Do No Harm  Journal Articles
• Anticoagulation for cardiopulmonary bypass: Is a replacement for heparin on the horizon?  Journal Articles
• Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding  Journal Articles
• Anticoagulation for patients with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for perioperative thromboprophylaxis in people with cancer  Journal Articles
• Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis  Journal Articles
• Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the prevention of central venous catheter associated-thrombosis: an evidence based commentary  Journal Articles
• Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters  Journal Articles
• Anticoagulation for venous thromboembolism  Journal Articles
• Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.  Journal Articles
• Anticoagulation in patients with cancer: an overview of reviews  Journal Articles
• Anticoagulation in patients with cerebral amyloid angiopathy  Journal Articles
• Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target  Journal Articles
• Anticoagulation in venous Thrombosis  Journal Articles
• Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion  Journal Articles
• Anticoagulation of Pregnant Women With Mechanical Heart Valves  Journal Articles
• Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada  Journal Articles
• Anticoagulation prescription among atrial fibrillation patients managed with and without an anticoagulant initiation pathway: a cohort study  Journal Articles
• Anticoagulation therapy in 2015: where we are and where we are going  Journal Articles
• Anticoagulation therapy in neonates, children and adolescents  Journal Articles
• Anticoagulation therapy in patients with prosthetic heart valves.  Journal Articles
• Anticoagulation therapy in the antiphospholipid syndrome: recent advances  Journal Articles
• Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients  Journal Articles
• Anticoagulation use in perioperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis  Journal Articles
• Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial  Journal Articles
• Anticoagulation/platelet inhibition for atrial fibrillation  Journal Articles
• Antidotes for Novel Oral Anticoagulants  Journal Articles
• Antiphospholipid Syndrome During Septic Shock: Hyper- or Hypocoagulability?: A Case Report  Journal Articles
• Antiphospholipid antibiodies: a critical review of the literature  Journal Articles
• Antiphospholipid antibodies and venous thromboembolism  Journal Articles
• Antiphospholipid antibody syndrome: further evidence to guide clinical practice?  Journal Articles
• Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.  Journal Articles
• Antiphospholipid syndrome  Journal Articles
• Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis  Journal Articles
• Antiplatelet drugs in thromboembolism  Journal Articles
• Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials  Journal Articles
• Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair  Journal Articles
• Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations  Journal Articles
• Antithrombin-Heparin Covalent Complex  Journal Articles
• Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin  Journal Articles
• Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model  Journal Articles
• Antithrombotic Activity of the Novel Oral Anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in Animal Models  Journal Articles
• Antithrombotic Agents  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Drugs  Journal Articles
• Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement.  Journal Articles
• Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Antithrombotic Therapy for Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Journal Articles
• Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Following Percutaneous Transluminal Coronary Angioplasty  Journal Articles
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Journal Articles
• Antithrombotic drugs for thromboembolic disorders: A lesson in evidence-based medicine  Journal Articles
• Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding  Journal Articles
• Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry  Journal Articles
• Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program  Journal Articles
• Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents  Journal Articles
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Journal Articles
• Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation  Journal Articles
• Antithrombotic therapy in aortic diseases: A narrative review  Journal Articles
• Antithrombotic therapy in atrial fibrillation.  Journal Articles
• Antithrombotic therapy in children with venous thromboembolism  Journal Articles
• Antithrombotic therapy in the management of hospitalised patients with COVID-19  Journal Articles
• Antithrombotic therapy: the expanding role of low molecular weight heparin.  Journal Articles
• Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation  Journal Articles
• Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme  Journal Articles
• Antithrombotic treatment for peripheral arterial disease  Journal Articles
• Antithrombotics and Anticoagulants in Coronary Syndromes and Stroke  Journal Articles
• Antithrombotics in stable peripheral artery disease  Journal Articles
• Anti‐PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis  Journal Articles
• Anti‐PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non‐drug risk factors and evidence for a stoichiometry‐based model of immunization  Journal Articles
• Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin  Journal Articles
• Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned  Journal Articles
• Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation  Journal Articles
• Apixaban in Acute Coronary Syndromes  Journal Articles
• Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy  Journal Articles
• Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement  Journal Articles
• Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients  Journal Articles
• Apixaban versus Enoxaparin in Medically Ill Patients  Journal Articles
• Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial  Journal Articles
• Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease  Journal Articles
• Approach to the new oral anticoagulants in family practice: part 1: comparing the options.  Journal Articles
• Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.  Journal Articles
• Approaches to Diagnosing and Managing Anticoagulant-Related Bleeding  Journal Articles
• Appropriate Apixaban Dosing  Journal Articles
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery  Journal Articles
• Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials  Journal Articles
• Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials  Journal Articles
• Are NSAIDs Double Trouble?  Journal Articles
• Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin?  Journal Articles
• Are Ticks the Answer to Medical Device-Associated Clotting?  Journal Articles
• Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.  Journal Articles
• Are heparins anti-neoplastic agents?  Journal Articles
• Are older patients with mechanical heart valves at increased risk?  Journal Articles
• Are placebo‐controlled trials ethical in areas where current guidelines recommend therapy? No  Journal Articles
• Are the correct outcomes being measured in studies of oral anticoagulants? A systematic survey  Journal Articles
• Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia  Journal Articles
• Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia  Journal Articles
• Argatroban as a Heparin Substitute in Cases of Heparin-Induced Thrombocytopenia  Journal Articles
• Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis  Journal Articles
• Arteriovenous-Shunt Thrombosis  Journal Articles
• Article Commentary: Heparin and the Peritoneal Membrane  Journal Articles
• Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty  Journal Articles
• Aspirin and Other Platelet-Active Drugs  Journal Articles
• Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.  Journal Articles
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Assays for Measuring Rivaroxaban: Their Suitability and Limitations  Journal Articles
• Assessing renal function in patients receiving DOACs: Cockcroft-Gault versus estimated glomerular filtration rate  Journal Articles
• Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants  Journal Articles
• Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin  Journal Articles
• Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials  Journal Articles
• Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH  Journal Articles
• Assessment of the optimal anticoagulant solution for storage of whole blood samples prior to measurement of platelet‐associated IgG  Journal Articles
• Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients  Journal Articles
• Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients  Journal Articles
• Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation  Journal Articles
• Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery  Journal Articles
• Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery  Journal Articles
• Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials  Journal Articles
• Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure  Journal Articles
• Association of atrial fibrillation with mortality and disability after ischemic stroke  Journal Articles
• Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis  Journal Articles
• Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study  Journal Articles
• Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study  Journal Articles
• Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment—A nationwide register‐based study  Journal Articles
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation  Journal Articles
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism  Journal Articles
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism  Journal Articles
• At What Age Does Stroke Risk Increase in Patients With Atrial Fibrillation? Does It Depend on Where You Live?  Journal Articles
• Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis  Journal Articles
• Atrial Fibrillation and Cancer—Validation in the Real World—Reply  Journal Articles
• Atrial Fibrillation and PCI — Do We Still Need Aspirin?  Journal Articles
• Atrial Fibrillation in Patients with Cryptogenic Stroke  Journal Articles
• Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?  Journal Articles
• Atrial fibrillation and stroke: who is low risk and what are we going to do about it?  Journal Articles
• Atrial fibrillation for internists: current practice  Journal Articles
• Atrial fibrillation in a primary care practice: prevalence and management  Journal Articles
• Author response to: Comment on: Timing of symptomatic venous thromboembolism after surgery: meta-analysis  Journal Articles
• Autoimmune heparin‐induced thrombocytopenia  Journal Articles
• Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review  Journal Articles
• BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study  Journal Articles
• Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach  Journal Articles
• Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation  Journal Articles
• Balancing the Risks and Benefits of Oral Anticoagulant Use in Patients With Postoperative Atrial Fibrillation  Journal Articles
• Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers  Journal Articles
• Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey  Journal Articles
• Barriers and facilitators to adopting high value practices and de-adopting low value practices in Canadian intensive care units: a multimethod study  Journal Articles
• Barriers and facilitators to optimal oral anticoagulant management: a scoping review  Journal Articles
• Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: A survey of healthcare professionals  Journal Articles
• Baseline Risks of Venous Thromboembolism and Major Bleeding are Crucial in Decision-making on Thromboprophylaxis  Journal Articles
• Basic and Translational Research in Intracerebral Hemorrhage  Journal Articles
• Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial  Journal Articles
• Benefit of Heparin in Central Venous and Pulmonary Artery Catheters  Journal Articles
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range  Journal Articles
• Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials  Journal Articles
• Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty  Journal Articles
• Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease  Journal Articles
• Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials  Journal Articles
• Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness  Journal Articles
• Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)  Journal Articles
• Beyond Unfractionated Heparin and Warfarin  Journal Articles
• Beyond heparin and warfarin: the new generation of anticoagulants  Journal Articles
• Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review  Journal Articles
• Biodistribution of covalent antithrombin-heparin complexes  Journal Articles
• Biologic rationale for the therapeutic role of specific antithrombins  Journal Articles
• Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation  Journal Articles
• Bivalirudin  Journal Articles
• Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.  Journal Articles
• Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non‐ST‐Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study (SWITCH III)  Journal Articles
• Bivalirudin: a review  Journal Articles
• Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation  Journal Articles
• Bleeding Complications in Acute Coronary Syndromes and Percutaneous Coronary Intervention: Predictors, Prognostic Significance, and Paradigms for Reducing Risk  Journal Articles
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Journal Articles
• Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials  Journal Articles
• Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis  Journal Articles
• Bleeding and antidotes in new oral anticoagulants  Journal Articles
• Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes  Journal Articles
• Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing  Journal Articles
• Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry  Journal Articles
• Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk.  Journal Articles
• Bleeding events with dabigatran or warfarin in patients with venous thromboembolism  Journal Articles
• Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology  Journal Articles
• Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study  Journal Articles
• Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation  Journal Articles
• Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents  Journal Articles
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Journal Articles
• Bleeding risks associated with vitamin K antagonists  Journal Articles
• Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience  Journal Articles
• Bleeding with direct oral anticoagulants vs warfarin: clinical experience  Journal Articles
• Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures  Journal Articles
• Bone marrow aspirate collection and preparation – A comparison of three methods  Journal Articles
• Bone marrow biopsy in thrombocytopenic or anticoagulated patients  Journal Articles
• Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation  Journal Articles
• Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study  Journal Articles
• Brand Name versus Generic Warfarin: A Systematic Review of the Literature  Journal Articles
• Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design  Journal Articles
• Bridging Anticoagulation  Journal Articles
• Bridging Anticoagulation in Patients with Atrial Fibrillation  Journal Articles
• Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation  Journal Articles
• Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery  Journal Articles
• Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT)  Journal Articles
• Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin  Journal Articles
• Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment  Journal Articles
• Burden of Illness in venous ThromboEmbolism in Critical care: a multicenter observational study  Journal Articles
• CHANGES IN PLATELET BEHAVIOUR DURING ARVIN THERAPY  Journal Articles
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up  Journal Articles
• Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case  Journal Articles
• Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?  Journal Articles
• Can we differentiate the low-molecular-weight heparins?  Journal Articles
• Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020  Journal Articles
• Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy  Journal Articles
• Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study  Journal Articles
• Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE  Journal Articles
• Capillary Whole Blood Monitoring of Oral Anticoagulants in Children in Outpatient Clinics and the Home Setting  Journal Articles
• Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation  Journal Articles
• Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial  Journal Articles
• Cardiac Tamponade During Uninterrupted Oral Anticoagulant Therapy for Catheter Ablation for Atrial Fibrillation  Journal Articles
• Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: experiences from the RELY trial  Conferences
• Cardiac involvement in hypereosinophilic syndrome  Journal Articles
• Cardioembolic Stroke  Journal Articles
• Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients  Journal Articles
• Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants  Journal Articles
• Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)  Journal Articles
• Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial  Journal Articles
• Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48  Journal Articles
• Care of Patients Receiving Long-Term Anticoagulant Therapy  Journal Articles
• Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention  Journal Articles
• Catheter-Associated Thrombosis: Thromboprophylaxis or Not?  Journal Articles
• Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF  Journal Articles
• Causes of Death and Influencing Factors in Patients With Atrial Fibrillation  Journal Articles
• Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS  Journal Articles
• Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia  Journal Articles
• Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline  Journal Articles
• Central venous catheters are an important factor in paediatric thrombosis  Journal Articles
• Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach  Journal Articles
• Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke  Journal Articles
• Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin  Journal Articles
• Certainty ranges facilitated explicit and transparent judgments regarding evidence credibility  Journal Articles
• Cervical artery dissection: Pathology, epidemiology and management  Journal Articles
• Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity  Journal Articles
• Challenging anticoagulation cases: A case of acute pulmonary embolism in a patient with chronic thrombocytopenia  Journal Articles
• Change in Thrombus Length on Venous Ultrasound and Recurrent Deep Vein Thrombosis  Journal Articles
• Changes in Renal Function in Patients With Atrial Fibrillation  Journal Articles
• Changes in renal cortical and medullary perfusion in a patient with renal vein thrombosis.  Journal Articles
• Changing Paradigms in the Management of Venous Thromboembolism  Journal Articles
• Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry  Journal Articles
• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial  Journal Articles
• Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry  Journal Articles
• Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)  Journal Articles
• Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin‐induced thrombocytopenia  Journal Articles
• Chemical–Physical Characterization of Polyurethane Catheters Modified with a Novel Antithrombin-Heparin Covalent Complex  Journal Articles
• Childhood nephrotic syndrome and the clinical profile of thromboembolism: a systematic review and meta-analysis  Journal Articles
• Choice of Platelet Anticoagulants  Journal Articles
• Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1  Journal Articles
• Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2  Journal Articles
• Ciraparantag as a potential universal anticoagulant reversal agent  Journal Articles
• Circulating heparin‐like anticoagulants: Case report and review of literature  Journal Articles
• Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism  Journal Articles
• Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study  Journal Articles
• Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism  Journal Articles
• Clinical Implications of Reversal Agents for Direct Oral Anticoagulants  Journal Articles
• Clinical Outcomes in Atrial Fibrillation Research  Journal Articles
• Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry  Journal Articles
• Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy  Journal Articles
• Clinical Studies with Anticoagulants that Have Changed Clinical Practice  Journal Articles
• Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective  Journal Articles
• Clinical Validity of a Normal Perfusion Lung Scan in Patients with Suspected Pulmonary Embolism  Journal Articles
• Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey  Journal Articles
• Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis  Journal Articles
• Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin‐induced thrombocytopenia  Journal Articles
• Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials  Journal Articles
• Clinical factors influencing the sensitivity to warfarin when restarted after surgery  Journal Articles
• Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis  Journal Articles
• Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry  Journal Articles
• Clinical history of cancer‐associated splanchnic vein thrombosis  Journal Articles
• Clinical implications of incidental venous thromboembolism in cancer patients  Journal Articles
• Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry  Journal Articles
• Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia  Journal Articles
• Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin  Journal Articles
• Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications  Journal Articles
• Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin‐induced thrombocytopenia (HIT)  Journal Articles
• Clinical significance and management of subsegmental pulmonary embolism  Journal Articles
• Clinical trials of deep vein thrombosis prophylaxis in medical patients  Journal Articles
• Clinical trials of new anticoagulants.  Journal Articles
• Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study  Journal Articles
• Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis.  Journal Articles
• Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial  Journal Articles
• Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices  Journal Articles
• Coagulation Assays  Journal Articles
• Coagulation Factor IXa as a Target for Treatment and Prophylaxis of Venous Thromboembolism  Journal Articles
• Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass  Journal Articles
• Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure  Journal Articles
• Cochrane in CORR ®: Pharmacological Interventions for the Prevention of Bleeding in People Undergoing Elective Hip or Knee Surgery: A Systematic Review and Network Meta-analysis  Journal Articles
• Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation  Journal Articles
• Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease  Journal Articles
• Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study  Journal Articles
• Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT)  Journal Articles
• Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?  Journal Articles
• Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease  Journal Articles
• Combined antiplatelet and anticoagulant therapy: clinical benefits and risks  Conferences
• Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist  Journal Articles
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Journal Articles
• Comment on model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients  Journal Articles
• Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”  Journal Articles
• Comment: Treatment of Heparin-Induced Thrombocytopenia  Journal Articles
• Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole  Journal Articles
• Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis: A Survey on Anticoagulation for Mechanical Heart Valves in Pregnancy  Journal Articles
• Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis  Journal Articles
• Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study  Journal Articles
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol  Journal Articles
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study  Journal Articles
• Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?  Journal Articles
• Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE  Journal Articles
• Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes  Journal Articles
• Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study  Journal Articles
• Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry  Journal Articles
• Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials  Journal Articles
• Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades  Journal Articles
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conferences
• Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor  Journal Articles
• Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy  Journal Articles
• Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin  Journal Articles
• Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease  Journal Articles
• Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome  Journal Articles
• Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy  Journal Articles
• Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism  Journal Articles
• Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes  Journal Articles
• Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease  Journal Articles
• Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement  Journal Articles
• Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)  Journal Articles
• Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial  Journal Articles
• Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)  Journal Articles
• Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial  Journal Articles
• Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial  Journal Articles
• Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial  Journal Articles
• Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model  Journal Articles
• Comparison of the Villalta post‐thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis  Journal Articles
• Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial  Journal Articles
• Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations  Journal Articles
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Journal Articles
• Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism  Journal Articles
• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials  Journal Articles
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis  Conferences
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.  Journal Articles
• Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers  Journal Articles
• Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials  Journal Articles
• Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients  Journal Articles
• Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism  Journal Articles
• Complement and the antiphospholipid syndrome  Journal Articles
• Comprehensive upstream treatment for atrial fibrillation, when and how?  Journal Articles
• Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial  Journal Articles
• Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial  Journal Articles
• Concentration of meropenem in patients with sepsis and acute kidney injury before and after initiation of continuous renal replacement therapy: a prospective observational trial  Journal Articles
• Concomitant Surgical Left Atrial Appendage Occlusion: a Review  Journal Articles
• Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial  Journal Articles
• Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial  Journal Articles
• Conduit selection and early graft failure in coronary artery bypass surgery: A post hoc analysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) coronary artery bypass grafting study  Journal Articles
• Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies – distinguishing "signal" from "noise"  Journal Articles
• Confusion Over the Therapeutic Range for Monitoring Oral Anticoagulant Therapy in North America  Journal Articles
• Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology  Journal Articles
• Conservative management of neonatal cerebral sinovenous thrombosis with coexisting thrombophilia  Journal Articles
• Considerations when prescribing trimethoprim-sulfamethoxazole  Journal Articles
• Continued versus interrupted direct oral anticoagulation for cardiac electronic device implantation: A systematic review  Journal Articles
• Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)  Journal Articles
• Continuing Challenges of Sepsis Research  Journal Articles
• Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery”  Journal Articles
• Controversies in Timing of the First Dose of Anticoagulant Prophylaxis Against Venous Thromboembolism After Major Orthopedic Surgery  Journal Articles
• Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.  Journal Articles
• Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trial  Journal Articles
• Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism  Journal Articles
• Cost Effectiveness of Continued-Warfarin Versus Heparin-Bridging Therapy During Pacemaker and Defibrillator Surgery  Journal Articles
• Cost effectiveness of LAA closure in patients with AF and contraindications to warfarin: comment  Journal Articles
• Cost prediction models for the comparison of two groups  Journal Articles
• Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis  Journal Articles
• Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation  Journal Articles
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Journal Articles
• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation  Journal Articles
• Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients  Journal Articles
• Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.  Journal Articles
• Costs of Outpatient Anticoagulant Treatment in Patients with Cerebral and Peripheral Arterial Occlusive Disease  Journal Articles
• Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke  Journal Articles
• Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis  Journal Articles
• Covalent Antithrombin-Heparin Complexes with High Anticoagulant Activity  Journal Articles
• Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes  Journal Articles
• Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va  Journal Articles
• Covalent antithrombin–heparin complexes  Journal Articles
• Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets  Journal Articles
• Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism.  Journal Articles
• Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics  Journal Articles
• Current agents for the treatment of patients with heparin-induced thrombocytopenia  Journal Articles
• Current anticoagulant therapy—unmet clinical needs  Conferences
• Current strategies in prophylaxis and treatment of venous thromboembolism  Journal Articles
• D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders  Journal Articles
• D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy  Journal Articles
• D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment  Journal Articles
• DEEP VEIN THROMBOSIS PROPHYLAXIS IN THE OUTPATIENT SETTING: PREVENTING COMPLICATIONS FOLLOWING HOSPITAL DISCHARGE  Journal Articles
• DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines  Journal Articles
• DRUG-THERAPY - ORAL ANTICOAGULANT DRUGS  Journal Articles
• Dabigatran Etexilate  Journal Articles
• Dabigatran Etexilate: Future Directions in Anticoagulant Treatment  Journal Articles
• Dabigatran Versus Warfarin  Journal Articles
• Dabigatran Versus Warfarin in Patients With Atrial Fibrillation  Journal Articles
• Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation  Journal Articles
• Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management  Journal Articles
• Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?  Journal Articles
• Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial  Journal Articles
• Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE‐LY trial  Journal Articles
• Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation  Journal Articles
• Dabigatran etexilate and reduction in serum apolipoprotein B  Journal Articles
• Dabigatran etexilate for prevention of venous thromboembolism  Journal Articles
• Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial  Journal Articles
• Dabigatran in Patients with Mechanical Heart Valves  Journal Articles
• Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation  Journal Articles
• Dabigatran monitoring made simple?  Journal Articles
• Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: A systematic review of the literature  Journal Articles
• Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II  Journal Articles
• Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.  Journal Articles
• Dabigatran versus Warfarin for Venous Thromboembolism  Journal Articles
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation  Journal Articles
• Dabigatran versus Warfarin in Patients with Mechanical Heart Valves  Journal Articles
• Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism  Journal Articles
• Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada  Journal Articles
• Dabigatran versus warfarin in patients with mechanical heart valves: reply  Journal Articles
• Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study  Journal Articles
• Dabigatran: ready for prime time?  Journal Articles
• Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer  Journal Articles
• Dalteparin and Heparin-Induced Thrombocytopenia  Journal Articles
• Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency  Journal Articles
• Dalteparin versus Unfractionated Heparin in Critically Ill Patients  Journal Articles
• Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients  Journal Articles
• Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)  Journal Articles
• Dealing with Drug-Induced Thrombocytopenia  Journal Articles
• Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol  Journal Articles
• Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed-methods pilot study  Journal Articles
• Decision curve analysis based on summary data  Journal Articles
• Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines  Journal Articles
• Decision-analysis modeling of effectiveness and cost-effectiveness of pharmacologic thromboprophylaxis for surgical inpatients using variable risk assessment models or other strategies  Journal Articles
• Decision‐analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injury  Journal Articles
• Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009)  Journal Articles
• Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential  Journal Articles
• Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass  Journal Articles
• Decreasing warfarin sensitivity during the first three months after heart valve surgery: Implications for dosing  Journal Articles
• Deep Vein Thrombosis Prophylaxis in Hospitalized Medical Patients: Current Recommendations, General Rates of Implementation, and Initiatives for Improvement  Journal Articles
• Deep Vein Thrombosis and Its Prevention in Critically Ill Adults  Journal Articles
• Deep vein thrombosis  Journal Articles
• Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge.  Journal Articles
• Deep vein thrombosis: update on diagnosis and management  Journal Articles
• Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors  Journal Articles
• Deep venous thrombosis in the medically ill.  Journal Articles
• Deep-Vein Thrombosis  Journal Articles
• Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis  Journal Articles
• Defining the heparin-binding domain of antithrombin  Journal Articles
• Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation  Journal Articles
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients  Journal Articles
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients  Journal Articles
• Definition of major bleeding used by US anticoagulation clinics  Journal Articles
• Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department  Journal Articles
• Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin  Journal Articles
• Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis  Journal Articles
• Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis  Journal Articles
• Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum  Journal Articles
• Demand on-demand testing for the diagnosis of heparin-induced thrombocytopenia  Journal Articles
• Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis.  Journal Articles
• Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home  Journal Articles
• Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)–5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non–ST-segment elevation acute coronary syndromes  Journal Articles
• Design of the rivaroxaban for heparin-induced thrombocytopenia study  Journal Articles
• Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis  Journal Articles
• Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial  Journal Articles
• Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis  Journal Articles
• Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry  Journal Articles
• Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial  Journal Articles
• Device Surgery without Interruption of Anticoagulation  Journal Articles
• Device surgery without interruption of anticoagulation.  Journal Articles
• Diagnosing central nervous system vasculitis in children  Journal Articles
• Diagnosis and Anticoagulant Treatment  Journal Articles
• Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation  Journal Articles
• Diagnostic Efficacy of Impedance Plethysmography for Clinically Suspected Deep-Vein Thrombosis  Journal Articles
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice  Journal Articles
• Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation  Journal Articles
• Differences in the safety profiles of two low-molecular-weight heparins  Journal Articles
• Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis  Journal Articles
• Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation  Journal Articles
• Direct Factor Xa and direct thrombin inhibitors: a clinical trial update.  Journal Articles
• Direct Oral Anticoagulant Dosing in Extremes of Body Weight: Time to Revisit the Guidelines?  Journal Articles
• Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding  Journal Articles
• Direct Oral Anticoagulants  Journal Articles
• Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis  Journal Articles
• Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex  Journal Articles
• Direct Oral Anticoagulants and Myocardial Infarction  Journal Articles
• Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials  Journal Articles
• Direct Oral Anticoagulants in the Real World  Journal Articles
• Direct Oral Anticoagulants in the Very Elderly  Journal Articles
• Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study  Journal Articles
• Direct Thrombin Inhibitors in Acute Coronary Syndromes  Journal Articles
• Direct and indirect costs of management of long‐term warfarin therapy in Canada  Journal Articles
• Direct oral anticoagulant dose selection: Challenging cases  Journal Articles
• Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information  Journal Articles
• Direct oral anticoagulants after bariatric surgery—What is the evidence?  Journal Articles
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials  Journal Articles
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.  Journal Articles
• Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis  Journal Articles
• Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review  Journal Articles
• Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysis  Journal Articles
• Direct oral anticoagulants: a practical guide for the emergency physician  Journal Articles
• Direct oral anticoagulants: evidence and unresolved issues  Journal Articles
• Direct thrombin inhibitors  Journal Articles
• Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention  Journal Articles
• Direct-Acting Oral Anticoagulants  Journal Articles
• Distal Femoral Osteochondroma Masquerading as Deep Vein Thrombosis in an Adolescent Male  Journal Articles
• Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia  Journal Articles
• Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread  Journal Articles
• Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry  Journal Articles
• Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis  Journal Articles
• Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial  Journal Articles
• Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?  Journal Articles
• Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?  Journal Articles
• Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?  Journal Articles
• Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?  Journal Articles
• Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis  Journal Articles
• Does rhythm or rate control strategy influence anticoagulant treatment in older patients with atrial fibrillation? Data from REPOSI  Journal Articles
• Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis  Journal Articles
• Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/  Journal Articles
• Dose Capping Enoxaparin Is Unjustified and Denies Patients With Acute Coronary Syndromes a Potentially Effective Treatment  Journal Articles
• Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement  Journal Articles
• Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome  Journal Articles
• Double Blind Pilot Randomized Trial Comparing Extended Anticoagulation to Placebo Following Major Lung Resection for Cancer  Journal Articles
• Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review  Journal Articles
• Drug–drug interactions with warfarin: A systematic review and meta‐analysis  Journal Articles
• Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence  Journal Articles
• Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity.  Journal Articles
• Dual surface modification with PEG and corn trypsin inhibitor: Effect of PEG:CTI ratio on protein resistance and anticoagulant properties  Journal Articles
• Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease  Journal Articles
• Duration of Anticoagulant Therapy for Venous Thrombosis  Journal Articles
• Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH  Journal Articles
• Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia  Journal Articles
• Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism  Journal Articles
• Duration of anticoagulant therapy for venous thromboembolism  Journal Articles
• Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials  Journal Articles
• Duration of anticoagulants in acute or recurrent venous thromboembolism  Journal Articles
• Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference  Journal Articles
• ENNOBLE-ATE trial: an open-label, randomised, multi-centre, observational study of edoxaban for children with cardiac diseases at risk of thromboembolism  Journal Articles
• Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial  Journal Articles
• Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive  Journal Articles
• Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis  Journal Articles
• Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review  Journal Articles
• Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction].  Journal Articles
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Journal Articles
• Editorial Commentary: A Patient-Specific Approach to Preventing Venous Thromboembolism After Hip Arthroscopy Is Essential  Journal Articles
• Editorial Commentary: Don't Worry About It—Hip Arthroscopy Is Safe From Venous Thromboembolism…Mostly Yes!  Journal Articles
• Edoxaban and amiodarone: interactions on multiple levels  Journal Articles
• Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease  Journal Articles
• Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves  Journal Articles
• Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism  Journal Articles
• Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer  Journal Articles
• Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study  Journal Articles
• Edoxaban for treatment of venous thromboembolism in patients with cancer  Journal Articles
• Edoxaban versus Warfarin in Patients with Atrial Fibrillation  Journal Articles
• Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial  Journal Articles
• Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism  Journal Articles
• Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma  Journal Articles
• Effect of Drugs on Platelets and Complications of Vascular Disease  Other
• Effect of Heparin Loading During Congenital Heart Operation on Thrombin Generation and Blood Loss  Journal Articles
• Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate  Journal Articles
• Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty  Journal Articles
• Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature  Journal Articles
• Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin  Journal Articles
• Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy  Journal Articles
• Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium  Journal Articles
• Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study  Journal Articles
• Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung  Journal Articles
• Effect of endothelium on the anticoagulant activity of a covalent antithrombin-heparin complex.  Journal Articles
• Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis  Journal Articles
• Effect of gaboon viper (Bitis gabonica) venom on blood coagulation, platelets, and the fibrinolytic enzyme system  Journal Articles
• Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.  Journal Articles
• Effect of non‐vitamin‐K oral anticoagulants on stroke severity compared to warfarin: a meta‐analysis of randomized controlled trials  Journal Articles
• Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis  Journal Articles
• Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure  Journal Articles
• Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro  Journal Articles
• Effect of sulfonation of segmented polyurethanes on the transient adsorption of fibrinogen from plasma: Possible correlation with anticoagulant behavior  Journal Articles
• Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes  Journal Articles
• Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival  Journal Articles
• Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography  Journal Articles
• Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes  Journal Articles
• Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism  Journal Articles
• Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events  Journal Articles
• Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi‐database cohort study with meta‐analysis  Journal Articles
• Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials  Journal Articles
• Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min  Journal Articles
• Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state  Journal Articles
• Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism  Journal Articles
• Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism  Journal Articles
• Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1  Journal Articles
• Effectiveness of Anticoagulants  Journal Articles
• Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials  Journal Articles
• Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial  Journal Articles
• Effects of Heat/Citric Acid Reprocessing on High-Flux Polysulfone Dialyzers  Journal Articles
• Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation  Journal Articles
• Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment  Journal Articles
• Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth  Journal Articles
• Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review  Journal Articles
• Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina  Journal Articles
• Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials  Journal Articles
• Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: comment  Journal Articles
• Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants  Journal Articles
• Efficacy and Safety of Anti-Xa-Guided Versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients  Journal Articles
• Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation  Journal Articles
• Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation  Journal Articles
• Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -  Journal Articles
• Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism  Journal Articles
• Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients  Journal Articles
• Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines  Journal Articles
• Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention  Journal Articles
• Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients  Journal Articles
• Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation  Journal Articles
• Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19  Journal Articles
• Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Journal Articles
• Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation  Journal Articles
• Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial  Journal Articles
• Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial  Journal Articles
• Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis  Journal Articles
• Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement  Journal Articles
• Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment  Journal Articles
• Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial  Journal Articles
• Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial  Journal Articles
• Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves  Journal Articles
• Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER^®, RE-COVER™ II, and RE-MEDY™  Journal Articles
• Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation  Journal Articles
• Eligibility for anticoagulation initiation in atrial fibrillation: Agreement between emergency physician and medical record review  Journal Articles
• Embolic Stroke of Undetermined Source  Journal Articles
• Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants  Journal Articles
• Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry  Journal Articles
• Emerging Anticoagulant Drugs  Journal Articles
• Emerging anticoagulant strategies  Journal Articles
• Emerging anticoagulants for the treatment of venous thromboembolism  Journal Articles
• Emerging themes in the treatment of venous thromboembolism  Journal Articles
• End of the road for heparin thromboprophylaxis  Journal Articles
• Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis  Journal Articles
• Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles  Journal Articles
• Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction  Journal Articles
• Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years  Journal Articles
• Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty  Journal Articles
• Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates  Journal Articles
• Enoxaparin in the Treatment of Deep Vein Thrombosis With or Without Pulmonary Embolism  Journal Articles
• Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery  Journal Articles
• Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction  Journal Articles
• Epidemiology of Thrombosis in Cancer  Journal Articles
• Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant—Reply  Journal Articles
• Establishing an Optimal Therapeutic Range for Coumarins  Journal Articles
• Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke  Journal Articles
• Ethnoracial variations in venous thrombosis: Implications for management, and a call to action  Journal Articles
• European and Australian stroke prevention in reversible ischaemia trial (ESPRIT) study group  Journal Articles
• European guidelines on peri-operative venous thromboembolism prophylaxis: first update.  Journal Articles
• European guidelines on peri-operative venous thromboembolism prophylaxis: first update.  Journal Articles
• Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants  Journal Articles
• Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis  Journal Articles
• Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study  Journal Articles
• Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents  Journal Articles
• Evaluation of a Thromboprophylaxis Quality Improvement Project in a Palliative Care Unit  Journal Articles
• Evaluation of a fast‐and‐frugal clinical decision algorithm (‘pathways’) on clinical outcomes in hospitalised patients with COVID‐19 treated with anticoagulants  Journal Articles
• Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy  Journal Articles
• Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.  Journal Articles
• Evaluation of direct oral anticoagulants in superficial-vein thrombosis – Authors' reply  Journal Articles
• Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation  Journal Articles
• Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials  Journal Articles
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant  Journal Articles
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.  Journal Articles
• Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis  Journal Articles
• Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis  Journal Articles
• Evidence and Clinical Judgment: Vena cava filters  Journal Articles
• Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis  Journal Articles
• Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis  Journal Articles
• Evidence-based treatment of the antiphospholipid syndrome  Journal Articles
• Evolving Treatments for Arterial and Venous Thrombosis  Journal Articles
• Evolving use of new oral anticoagulants for treatment of venous thromboembolism  Journal Articles
• Exaggerated initial response to warfarin following heart valve replacement  Journal Articles
• Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial  Journal Articles
• Executive Summary  Journal Articles
• Executive Summary  Journal Articles
• Exercise-Induced Deep Vein Thrombosis of the Upper Extremity  Journal Articles
• Exercise-Induced Deep Vein Thrombosis of the Upper Extremity  Journal Articles
• Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor II  Journal Articles
• Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism  Journal Articles
• Extended DOAC therapy in patients with VTE and potential risk of recurrence: A systematic review and meta‐analysis  Journal Articles
• Extended Treatment of Venous Thromboembolism  Journal Articles
• Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study  Journal Articles
• Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study  Journal Articles
• Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?  Journal Articles
• Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review  Journal Articles
• Extended treatment of venous thromboembolism.  Journal Articles
• Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility  Journal Articles
• Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials  Journal Articles
• Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study  Journal Articles
• Extended‐duration new oral anticoagulants for venous thromboprophylaxis in patients undergoing total hip arthroplasty: a meta‐analysis of the randomized controlled trials  Journal Articles
• Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood  Journal Articles
• Extension of anticoagulation after venous thromboembolism  Journal Articles
• FEASIBILITY AND SAFETY OF FULL DOSE ANTICOAGULATION THERAPY (ACT) IN CHILDREN TREATED ACCORDING TO DANA-FARBER CANCER INSTITUTE (DFCI) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CONSORTIUM THERAPY PROTOCOLS  Conferences
• FRAIL-AF Study: More Bleeding With DOACs Compared With VKAs in Patients With Frailty?  Journal Articles
• Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis  Journal Articles
• Factor XI Antisense Oligonucleotide for Venous Thrombosis  Journal Articles
• Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease  Journal Articles
• Factor XI and factor XII as targets for new anticoagulants  Journal Articles
• Factor XI as a Target for New Anticoagulants  Journal Articles
• Factor XI inhibition in cardiovascular disease  Journal Articles
• Factor XI inhibitors: cardiovascular perspectives  Journal Articles
• Factor XI inhibitors: what should clinicians know  Journal Articles
• Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi  Journal Articles
• Factor XIa inhibition as a therapeutic strategy for atherothrombosis  Journal Articles
• Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial  Journal Articles
• Factor Xa and thrombin as targets for new oral anticoagulants  Journal Articles
• Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism  Journal Articles
• Factors affecting stability of plasma brain-derived neurotrophic factor  Journal Articles
• Failure of Anticoagulant Thromboprophylaxis  Journal Articles
• Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records  Journal Articles
• Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists  Journal Articles
• Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review  Journal Articles
• FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia  Journal Articles
• Feasibility and safety of delivering full‐dose anticoagulation therapy in children treated according to Dana‐Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols  Journal Articles
• Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates  Journal Articles
• Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study  Journal Articles
• Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT  Journal Articles
• Fifty years of research on antithrombotic therapy: Achievements and disappointments  Journal Articles
• Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors  Journal Articles
• Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty  Journal Articles
• Flexibility in Administration of Fondaparinux for Prevention of Symptomatic Venous Thromboembolism in Orthopaedic Surgery  Journal Articles
• Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control  Journal Articles
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Journal Articles
• Fondaparinux Reduces Long-term Risk of Venous Thromboembolism After Surgery for Hip Fractur  Journal Articles
• Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison  Journal Articles
• Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk  Journal Articles
• Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia  Journal Articles
• Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs  Journal Articles
• Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study  Journal Articles
• Fondaparinux in the management of patients with ST-elevation acute myocardial infarction  Journal Articles
• Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6  Journal Articles
• Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke  Journal Articles
• Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series  Journal Articles
• Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial  Journal Articles
• Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin  Journal Articles
• Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle>  Journal Articles
• Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux  Journal Articles
• Fondaparinux – evolution or revolution in anticoagulant care?  Journal Articles
• Fondaparinux: does it cause HIT? can it treat HIT?  Journal Articles
• For How Long Should the Treatment with Vitamin K Antagonists Be Maintained?  Conferences
• Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding  Journal Articles
• Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors  Journal Articles
• Fragmin in Unstable Angina Pectoris or in Non-Q-Wave Acute Myocardial Infarction (the FRIC Study)  Journal Articles
• Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants  Journal Articles
• Frequency of Heparin‐Induced Thrombocytopenia in Critical Care Patients  Journal Articles
• Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study  Journal Articles
• From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer  Journal Articles
• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)  Journal Articles
• Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey  Journal Articles
• GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation  Journal Articles
• GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide  Journal Articles
• GASTROINTESTINAL BLEEDING AFTER ACUTE ISCHEMIC STROKE  Journal Articles
• Gastrointestinal Bleeding With Edoxaban Versus Warfarin  Journal Articles
• Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies  Journal Articles
• Gender and left atrial appendage occlusion: Not the exception in cardiovascular procedures  Journal Articles
• General Discussion  Journal Articles
• General mechanisms of coagulation and targets of anticoagulants (Section I)  Journal Articles
• Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding  Journal Articles
• Genetic Determinants of Warfarin Maintenance Dose and Time in Therapeutic Treatment Range: A RE-LY Genomics Substudy  Journal Articles
• Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation  Journal Articles
• Getting intimate with the venous thrombus  Journal Articles
• Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE)  Journal Articles
• Global access to affordable direct oral anticoagulants  Journal Articles
• Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH  Journal Articles
• Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial  Journal Articles
• Guidance for the treatment of deep vein thrombosis and pulmonary embolism  Journal Articles
• Guide to Anticoagulant Therapy: Heparin  Journal Articles
• Guide to Anticoagulant Therapy: Heparin  Journal Articles
• Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.  Journal Articles
• Guideline No. 417: Prevention of Venous Thromboembolic Disease in Gynaecological Surgery  Journal Articles
• Guidelines for anticoagulant use in acute coronary syndromes  Journal Articles
• Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.  Journal Articles
• Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary and Renal Considerations: Executive Summary  Journal Articles
• Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations  Journal Articles
• Guidelines for the management of acute coronary syndromes 2006  Journal Articles
• HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions  Journal Articles
• HEART FAILURE SOCIETY OF AMERICA (HFSA) PRACTICE GUIDELINES  Journal Articles
• HERDOO2 identified women at low risk for recurrence after 5 to 12 mo of anticoagulation for a first unprovoked VTE  Journal Articles
• HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches  Journal Articles
• HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT  Journal Articles
• HITlights: A career perspective on heparin‐induced thrombocytopenia  Journal Articles
• Haemorrhagic and Thromboembolic Complications versus Intensity of Treatment of Venous Thromboembolism with Oral Anticoagulants  Journal Articles
• Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants.  Journal Articles
• Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin  Journal Articles
• Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis  Journal Articles
• Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding  Journal Articles
• Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study  Journal Articles
• Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.  Journal Articles
• Hemorrhagic Complications of Anticoagulant Therapy  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment  Journal Articles
• Hemorrhagic Complications of Long-term Anticoagulant Therapy  Journal Articles
• Hemorrhagic Complications of Long-term Anticoagulant Therapy  Journal Articles
• Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated?  Journal Articles
• Hemorrhagic complications of anticoagulant treatment.  Journal Articles
• Hemorrhagic complications of anticoagulant treatment.  Journal Articles
• Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.  Journal Articles
• Hemorrhagic complications of long-term anticoagulant therapy.  Journal Articles
• Hemorrhagic complications of long-term anticoagulant therapy.  Journal Articles
• Hemostasis and atherosclerosis.  Journal Articles
• Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways  Journal Articles
• Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.  Journal Articles
• Heparin Brand Is Associated With Postsurgical Outcomes in Children Undergoing Cardiac Surgery  Journal Articles
• Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate  Journal Articles
• Heparin Improves Gas Exchange during Experimental Acute Lung Injury in Newborn Piglets  Journal Articles
• Heparin Thromboprophylaxis in Medical-Surgical Critically Ill Patients  Journal Articles
• Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss  Journal Articles
• Heparin and Low-Molecular-Weight Heparin  Journal Articles
• Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety  Journal Articles
• Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases  Journal Articles
• Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Journal Articles
• Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?  Journal Articles
• Heparin for prolonging peripheral intravenous catheter use in neonates  Journal Articles
• Heparin induced thrombocytopenia  Journal Articles
• Heparin or nonheparin anticoagulants for VITT  Journal Articles
• Heparin resistance in acute coronary syndromes  Journal Articles
• Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns  Journal Articles
• Heparin, Low Molecular Weight Heparin, and Heparin-Induced Thrombocytopenia in the ICU  Journal Articles
• Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia Associated with Fondaparinux  Journal Articles
• Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages  Journal Articles
• Heparin-Induced Thrombocytopenia and Vascular Surgery  Journal Articles
• Heparin-Induced Thrombocytopenia in Critically Ill Patients  Journal Articles
• Heparin-Induced Thrombocytopenia in Critically Ill Patients  Journal Articles
• Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness  Journal Articles
• Heparin-Induced Thrombocytopenia in Patients with Ventricular Assist Devices: Are New Prevention Strategies Required?  Journal Articles
• Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing  Journal Articles
• Heparin-Induced Thrombocytopenia: A Clinicopathologic Syndrome  Journal Articles
• Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective  Journal Articles
• Heparin-Induced Thrombocytopenia: An Iceberg Rising  Journal Articles
• Heparin-Induced Thrombocytopenia: Real-World Issues  Journal Articles
• Heparin-induced Thrombocytopenia: Towards Consensus  Journal Articles
• Heparin-induced Thrombocytopenia: Yet Another Treatment Paradox?  Journal Articles
• Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes  Journal Articles
• Heparin-induced thrombocytopenia  Journal Articles
• Heparin-induced thrombocytopenia  Journal Articles
• Heparin-induced thrombocytopenia  Journal Articles
• Heparin-induced thrombocytopenia and cardiac surgery  Journal Articles
• Heparin-induced thrombocytopenia and cardiac surgery  Journal Articles
• Heparin-induced thrombocytopenia and its treatment.  Conferences
• Heparin-induced thrombocytopenia and the anesthesiologist.  Journal Articles
• Heparin-induced thrombocytopenia in intensive care patients  Journal Articles
• Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass  Journal Articles
• Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^  Journal Articles
• Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial  Journal Articles
• Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings  Journal Articles
• Heparin-induced thrombocytopenia: What the serologists have taught us  Journal Articles
• Heparin-induced thrombocytopenia: an overview  Journal Articles
• Heparin-induced thrombocytopenia: patient profiles and clinical manifestations.  Journal Articles
• Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety  Journal Articles
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Journal Articles
• Heparins in sepsis-induced disseminated intravascular coagulation: Low weight—high impact?*  Journal Articles
• Heparin‐induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT  Journal Articles
• Heparin‐induced thrombocytopenia: pathogenesis and management  Journal Articles
• Heparin‐induced thrombocytopenia: pathogenesis and management  Journal Articles
• High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis  Journal Articles
• High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT  Journal Articles
• Higher-quality evidence needed before abandoning proven therapies: Comment  Journal Articles
• Higher-risk APS: do we dare to DOAC?  Journal Articles
• Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14–16, 2010, São Paulo, Brazil  Journal Articles
• Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil  Journal Articles
• Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil  Journal Articles
• High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome  Journal Articles
• Hirudin and thrombosis prophylaxis  Journal Articles
• Hirudin causes more bleeding than heparin in a rabbit ear bleeding model  Journal Articles
• Home prophylactic warfarin anticoagulation program after hip and knee arthroplasty.  Journal Articles
• Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis  Journal Articles
• Home-monitoring of oral anticoagulation vs. dabigatran  Journal Articles
• Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone  Journal Articles
• How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review  Journal Articles
• How Did We Get Here?: A Historical Review and Critical Analysis of Anticoagulation Therapy Following Mechanical Valve Replacement  Journal Articles
• How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism  Journal Articles
• How I treat anticoagulated patients undergoing an elective procedure or surgery  Journal Articles
• How I treat heavy menstrual bleeding associated with anticoagulants  Journal Articles
• How I treat patients with a history of heparin-induced thrombocytopenia  Journal Articles
• How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy  Journal Articles
• How I treat target-specific oral anticoagulant–associated bleeding  Journal Articles
• How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch  Journal Articles
• How can we reverse bleeding in patients on direct oral anticoagulants?  Journal Articles
• How do family medicine residents choose an anticoagulation regimen for patients with nonvalvular atrial fibrillation?  Journal Articles
• How long is long enough for pharmacological thromboprophylaxis in urology?  Journal Articles
• How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society  Journal Articles
• How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice  Journal Articles
• How to use unfractionated heparin to treat neonatal thrombosis in clinical practice  Journal Articles
• How we diagnose and treat deep vein thrombosis  Journal Articles
• Hypercoagulability and coronavirus disease 2019–associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms  Journal Articles
• Hypercoagulability preceding cancer  Journal Articles
• Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase  Journal Articles
• Hypothenar Hammer Syndrome From Ice Hockey Stick-Handling  Journal Articles
• IMPACT OF MUTATIONS AT THE P4 AND P5 POSITIONS ON THE REACTION OF ANTITHROMBIN WITH THROMBIN AND ELASTASE  Journal Articles
• INR reporting in Canadian medical laboratories  Journal Articles
• INR reporting in Canadian medical laboratories. Thrombosis Interest Group of Canada.  Journal Articles
• INVIVO EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS ON EXPERIMENTAL THROMBOSIS AND BLEEDING  Journal Articles
• ISTH DIC subcommittee communication on anticoagulation in COVID‐19  Journal Articles
• ISTH guidelines for antithrombotic treatment in COVID‐19  Journal Articles
• Iatrogenic causes of an ICH  Journal Articles
• Idarucizumab for Dabigatran Reversal  Journal Articles
• Idarucizumab for Dabigatran Reversal — Full Cohort Analysis  Journal Articles
• Identifying Patients With Atrial Fibrillation in Administrative Data  Journal Articles
• Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy  Journal Articles
• Idrabiotaparinux treatment for venous thromboembolism  Journal Articles
• Imaging for Atrial Fibrillation  Journal Articles
• Immobilization of an antithrombin–heparin complex on gold: Anticoagulant properties and platelet interactions  Journal Articles
• Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin  Journal Articles
• Immune mechanisms in heparin‐induced thrombocytopenia: no evidence for immunoglobulin M anti‐idiotype antibodies  Journal Articles
• Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding  Journal Articles
• Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting  Journal Articles
• Impact of Evidence‐Based Stroke Care on Patient Outcomes: A Multilevel Analysis of an International Study  Journal Articles
• Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial  Journal Articles
• Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy  Journal Articles
• Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients  Journal Articles
• Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta‐analysis  Journal Articles
• Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry  Journal Articles
• Impact of the patient population on the risk for heparin-induced thrombocytopenia  Journal Articles
• Impact of thrombophilia screening on venous thromboembolism management practices  Journal Articles
• Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement  Journal Articles
• Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation  Journal Articles
• Improving Clinical Interpretation of the Anti-Platelet Factor 4/Heparin Enzyme-Linked Immunosorbent Assay for the Diagnosis of Heparin-Induced Thrombocytopenia Through the Use of Receiver Operating Characteristic Analysis, Stratum-Specific Likelihood Ratios, and Bayes Theorem  Journal Articles
• Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes  Journal Articles
• Improving the adoption of optimal venous thromboembolism prophylaxis in critically ill patients: A process evaluation of a complex quality improvement initiative  Journal Articles
• In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age  Journal Articles
• In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level  Journal Articles
• In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding  Journal Articles
• In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants  Journal Articles
• In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS₂and CHA₂DS₂-VASc  Journal Articles
• In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days  Journal Articles
• In reply: Low‐molecular‐weight heparins and heparinoids  Journal Articles
• In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation  Journal Articles
• In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding  Journal Articles
• In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex  Journal Articles
• Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgery  Journal Articles
• Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy  Journal Articles
• Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study  Conferences
• Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism  Journal Articles
• Incidence of Direct Oral Anticoagulant Prescriptions in Kidney Transplant Recipients in Ontario, Canada  Journal Articles
• Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy  Journal Articles
• Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta‐analysis of prospective studies  Journal Articles
• Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer  Journal Articles
• Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study  Journal Articles
• Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study  Journal Articles
• Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation  Journal Articles
• Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries  Journal Articles
• Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate  Journal Articles
• Incremental Value of Left Ventricular Systolic and Diastolic Function to Determine Outcome in Patients with Acute ST‐Segment Elevation Myocardial Infarction: The Echocardiographic Substudy of the OASIS‐6 Trial  Journal Articles
• Indications, Complications, and Management of Inferior Vena Cava Filters  Journal Articles
• Indications, complications and outcomes of inferior vena cava filters: A retrospective study  Journal Articles
• Indirect comparison: relative risk fallacies and odds solution  Journal Articles
• Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale  Journal Articles
• Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation  Journal Articles
• Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC‐AF risk scores  Journal Articles
• Individualized Care in Patients with Chronic Congestive Heart Failure  Journal Articles
• Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE  Journal Articles
• Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial  Journal Articles
• Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials  Journal Articles
• Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial  Journal Articles
• Influenza Vaccination and Vitamin K Antagonist Treatment  Journal Articles
• Influenza vaccination in patients on long-term anticoagulant therapy  Journal Articles
• Inherited thrombophilia and pregnancy associated venous thromboembolism  Journal Articles
• Inhibition of Warfarin Activity by Ribavirin  Journal Articles
• Inhibition of osteolytic bone metastasis by unfractionated heparin  Journal Articles
• Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes.  Journal Articles
• Inhibition of the prothrombinase complex on red blood cells by heparin and covalent antithrombin-heparin complex  Journal Articles
• Initial and long-term treatment of deep venous thrombosis: recent clinical trials and their impact on patient management  Journal Articles
• Initial treatment of venous thromboembolism  Journal Articles
• Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey  Journal Articles
• Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome  Journal Articles
• Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool  Journal Articles
• Integrating Clinical Decision Support into EMR and PHR: a Case Study Using Anticoagulation.  Journal Articles
• Integrating Electronic Health Records in the Delivery of Optimized Anticoagulation Therapy  Journal Articles
• Intensity and Quality of Warfarin Anticoagulation in Chinese Patients  Journal Articles
• Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome  Journal Articles
• Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis  Journal Articles
• International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism: Harmony, Dissonance, and Silence.  Journal Articles
• International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding  Journal Articles
• International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants  Journal Articles
• International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis  Journal Articles
• International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer  Journal Articles
• International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)  Journal Articles
• International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries  Journal Articles
• Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism  Journal Articles
• Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use  Journal Articles
• Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema  Journal Articles
• Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments  Journal Articles
• Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran  Journal Articles
• Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy  Journal Articles
• Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.  Journal Articles
• Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study  Journal Articles
• Intracranial hemorrhage in patients treated for SARS-CoV-2 with extracorporeal membrane oxygenation: A systematic review and meta-analysis  Journal Articles
• Intraoperative Heparin Flushes and Subsequent Acute Heparin-induced Thrombocytopenia   Journal Articles
• Intravascular Targeting of a New Anticoagulant Heparin Compound  Journal Articles
• Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia  Journal Articles
• Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials  Journal Articles
• Investigation of the Anticoagulant Mechanisms of a Covalent Antithrombin-Heparin Complex  Journal Articles
• Investigations of the effectiveness of heparin variants as inhibitors of histones  Journal Articles
• Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation?  Journal Articles
• Is There a Role for Betrixaban to Prevent Stroke in Medically Ill Patients?  Journal Articles
• Is aspirin safer than a direct oral anticoagulant for patients with atrial fibrillation at high risk of bleeding?  Journal Articles
• Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?  Journal Articles
• Is the network meta-analysis (NETMA) bringing us closer to the truth? Insights from recent antithrombotic drug data  Journal Articles
• Is the warfarin saga over?  Journal Articles
• Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?  Journal Articles
• Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials  Journal Articles
• Is there really misuse and abuse of dabigatran?  Journal Articles
• Is venous thromboembolism a preventable cause of death?  Journal Articles
• Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48  Journal Articles
• Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy  Journal Articles
• Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry  Journal Articles
• Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery  Journal Articles
• Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery  Journal Articles
• Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation  Journal Articles
• Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study  Journal Articles
• Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants  Journal Articles
• Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation  Journal Articles
• Laboratory Monitoring of Oral Vitamin K Anticoagulation  Journal Articles
• Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study  Journal Articles
• Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants  Journal Articles
• Laboratory diagnosis of heparin‐induced thrombocytopenia  Journal Articles
• Laboratory measurement of the direct oral anticoagulants  Journal Articles
• Laboratory monitoring of oral anticoagulant therapy.  Journal Articles
• Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: A survey of North American specialized coagulation laboratories  Journal Articles
• Laboratory testing for heparin-induced thrombocytopenia.  Journal Articles
• Laboratory testing for heparin‐induced thrombocytopenia: a conceptual framework and implications for diagnosis  Journal Articles
• Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials  Journal Articles
• Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016–2017  Journal Articles
• Latest medical treatment strategies for venous thromboembolism  Journal Articles
• Left Atrial Appendage Occlusion  Journal Articles
• Left Atrial Appendage Occlusion Debate Revisited  Journal Articles
• Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin  Journal Articles
• Left Atrial Appendage Occlusion Eliminates the Need for Warfarin  Journal Articles
• Left Atrial Appendage Occlusion Study II (LAAOS II)  Journal Articles
• Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke  Journal Articles
• Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials  Journal Articles
• Less menorrhagia for women with VTE  Journal Articles
• Letter by de Vries et al Regarding Article “Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis”  Journal Articles
• Letter to the Editor  Journal Articles
• Letter to the editor  Journal Articles
• Letter: Commentary: What We Might or Might Not Know About Venous Thromboembolism Prophylaxis in Neurosurgery  Journal Articles
• Limitations of Administrative Data for Examining Secondary Atrial Fibrillation  Journal Articles
• Limitations of conventional treatment options for heparin-induced thrombocytopenia.  Journal Articles
• Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial  Journal Articles
• Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis  Journal Articles
• Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials  Journal Articles
• Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction  Journal Articles
• Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis  Journal Articles
• Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation?  Conferences
• Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism  Journal Articles
• Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis  Journal Articles
• Long-term Clinical Outcomes of Splanchnic Vein Thrombosis  Journal Articles
• Long-term Follow-up of the Implementation of a Venous Thromboembolism Prophylaxis Order Set on a Cardiology Ward: Still a Surprising Result?  Journal Articles
• Long-term anticoagulant therapy - Reply  Journal Articles
• Long-term anticoagulant therapy in patients with venous thrombosis  Journal Articles
• Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation  Journal Articles
• Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event  Journal Articles
• Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis  Journal Articles
• Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference  Journal Articles
• Long‐term management of venous thromboembolism: is there a role for low‐intensity warfarin therapy?  Journal Articles
• Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study  Journal Articles
• Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study  Journal Articles
• Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis  Journal Articles
• Looking forward in the treatment of deep-vein thrombosis  Journal Articles
• Low Dose Oral Vitamin K to Reverse Acenocoumarol-induced Coagulopathy: A Randomized Controlled Trial  Journal Articles
• Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism  Journal Articles
• Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery  Journal Articles
• Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results  Journal Articles
• Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)  Journal Articles
• Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism  Conferences
• Low Use of Oral Anticoagulant Prescribing for Secondary Stroke Prevention  Journal Articles
• Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.  Journal Articles
• Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.  Journal Articles
• Low molecular weight heparin and bleeding in patients with chronic renal failure  Journal Articles
• Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels  Journal Articles
• Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial  Journal Articles
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Low molecular weight heparins and heparinoids  Journal Articles
• Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation  Journal Articles
• Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial  Journal Articles
• Low-Intensity Adjusted-Dose Warfarin for the Prevention of Hemodialysis Catheter Failure  Journal Articles
• Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis  Journal Articles
• Low-Intensity versus Conventional-Intensity Warfarin for Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Low-Molecular-Weight Heparin Did Not Differ from Placebo in Preventing Clinically Important Deep Venous Thrombosis After Surgical Repair of Leg Fracture  Journal Articles
• Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients  Journal Articles
• Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin  Journal Articles
• Low-Molecular-Weight Heparin as an Adjunct to Thrombolysis in ST Elevation Myocardial Infarction  Journal Articles
• Low-Molecular-Weight Heparin for Anticoagulation During Continuous Venovenous Hemofiltration—Reply  Journal Articles
• Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results  Journal Articles
• Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism  Journal Articles
• Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients  Journal Articles
• Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer  Journal Articles
• Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial  Journal Articles
• Low-Molecular-Weight Heparin: From the Bench to the Orthopedic Patient  Journal Articles
• Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture  Journal Articles
• Low-Molecular-Weight Heparins  Journal Articles
• Low-Molecular-Weight Heparins in Acute Unstable Coronary Artery Disease – An Update  Journal Articles
• Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin  Journal Articles
• Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10  Journal Articles
• Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review  Journal Articles
• Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin  Journal Articles
• Low-dose warfarin in rehabilitating stroke survivors  Journal Articles
• Low-molecular-weight heparin for anticougulation during continuous venovenous hemofiltration - Reply  Journal Articles
• Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants  Journal Articles
• Low-molecular-weight heparin for the treatment of venous thromboembolism  Conferences
• Low-molecular-weight heparin for the treatment of venous thromboembolism.  Journal Articles
• Low-molecular-weight heparin in patients with chronic renal insufficiency  Journal Articles
• Low-molecular-weight heparin in the treatment of pulmonary embolism.  Journal Articles
• Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review  Journal Articles
• Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial  Journal Articles
• Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis  Journal Articles
• Low-molecular-weight heparin: from the bench to the orthopedic patient.  Journal Articles
• Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review  Journal Articles
• Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency  Journal Articles
• Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.  Journal Articles
• Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial  Conferences
• Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Journal Articles
• Low‐molecular‐weight heparins and heparinoids  Journal Articles
• MAA868 locks factor XIa in a zymogen-like state  Journal Articles
• Maculopathy caused by pentosan polysulfate  Journal Articles
• Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study  Journal Articles
• Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials  Journal Articles
• Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation  Journal Articles
• Major bleeding during anticoagulation after cerebral ischemia  Journal Articles
• Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups.  Journal Articles
• Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy  Journal Articles
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Journal Articles
• Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry  Journal Articles
• Management and Monitoring of Anticoagulation for Children Undergoing Cardiopulmonary Bypass in Cardiac Surgery  Journal Articles
• Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin  Journal Articles
• Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting  Journal Articles
• Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor  Journal Articles
• Management of Anticoagulation Around Pacemaker and Defibrillator Surgery  Journal Articles
• Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction: Challenging Cases and Practical Algorithms  Journal Articles
• Management of Anticoagulation before and after Elective Surgery  Journal Articles
• Management of Antiphospholipid Antibody Syndrome  Journal Articles
• Management of Bleeding Complications in the Anticoagulated Patient  Journal Articles
• Management of Bleeding in Patients Receiving Conventional or New Anticoagulants  Journal Articles
• Management of Deep Vein Thrombosis and Pulmonary Embolism  Journal Articles
• Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists  Journal Articles
• Management of Patients on Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Peri-Endoscopic Period: A Clinical Practice Guideline Dissemination Tool  Journal Articles
• Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy  Journal Articles
• Management of Severe Mitral Stenosis During Pregnancy  Journal Articles
• Management of Venous Thromboembolism: Present and Future  Journal Articles
• Management of Venous Thrombosis in Cancer. Recent Developments in Diagnosis, Prevention, and Treatment  Journal Articles
• Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health‐care providers  Journal Articles
• Management of bleeding complications in patients with cancer on DOACs  Journal Articles
• Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease  Journal Articles
• Management of bleeding with oral anticoagulants in patients with atrial fibrillation  Journal Articles
• Management of cancer-associated upper extremity deep vein thrombosis with and without venous catheters at a tertiary care center  Journal Articles
• Management of direct oral anticoagulant associated bleeding: Results of a multinational survey  Journal Articles
• Management of heparin-induced thrombocytopenia  Journal Articles
• Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban  Journal Articles
• Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses  Journal Articles
• Management of heterotopic ossification and venous thromboembolism following acquired brain injury  Journal Articles
• Management of intentional overdose of low-molecular-weight heparin  Journal Articles
• Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report  Journal Articles
• Management of patients who are receiving warfarin or a new oral anticoagulant and require urgent or emergency surgery  Journal Articles
• Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey  Journal Articles
• Management of unstable coronary-artery disease  Journal Articles
• Management of venous thromboembolism in cancer patients.  Journal Articles
• Management of venous thromboembolism in patients with cancer: role of dalteparin  Journal Articles
• Management strategies in unstable coronary artery disease—Current problems and future directions  Journal Articles
• Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting  Journal Articles
• Managing Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Device Surgery: Canadian Survey  Journal Articles
• Managing Oral Anticoagulant Therapy  Journal Articles
• Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents  Conferences
• Managing challenging patients with venous thromboembolism: a practical, case-based approach  Journal Articles
• Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery  Journal Articles
• Managing oral anticoagulant therapy.  Journal Articles
• Managing pain medications in long-term care: nurses' views  Journal Articles
• Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer  Journal Articles
• Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides  Journal Articles
• Maximum 24‐hour platelet count fall: Metric for improving the diagnosis of heparin‐induced thrombocytopenia among patients with intermediate probability 4Ts scores  Journal Articles
• Measuring the anticoagulant effect of low molecular weight heparins in the critically ill.  Journal Articles
• Mechanical valves  Journal Articles
• Mechanism of Action and Monitoring of Anticoagulants  Journal Articles
• Mechanism of Action and Pharmacology of Unfractionated Heparin  Journal Articles
• Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo  Journal Articles
• Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex  Journal Articles
• Mechanisms and Clinical Manifestations of Cognitive Decline in Atrial Fibrillation Patients: Potential Implications for Preventing Dementia  Journal Articles
• Mechanisms for the Anticoagulant Effects of Synthetic Antithrombins  Journal Articles
• Mechanisms for the anticoagulant effect of heparin and related polysaccharides.  Journal Articles
• Mechanisms responsible for the failure of protamine 
to inactivate low‐molecular‐weight heparin  Journal Articles
• Medical device‐induced thrombosis: what causes it and how can we prevent it?  Journal Articles
• Meeting the Unmet Needs in Anticoagulant Therapy  Journal Articles
• Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency  Journal Articles
• Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery  Journal Articles
• Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients  Journal Articles
• Metabolic and Bariatric Surgery in Patients with Obesity Class V (BMI > 60 kg/m2): a Modified Delphi Study  Journal Articles
• Meta‐Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study  Journal Articles
• Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation  Journal Articles
• Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity  Journal Articles
• Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source  Journal Articles
• Milestones in VTE treatment. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 2  Journal Articles
• Milvexian for the Prevention of Venous Thromboembolism  Journal Articles
• Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.  Journal Articles
• Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35‐day cold‐storage regardless of leukoreduction timing  Journal Articles
• Minimizing errors of omission: Behavioural rEenforcement of Heparin to Avert Venous Emboli: The BEHAVE Study*  Journal Articles
• Molecular Basis for the Resistance of Fibrin-Bound Thrombin to Inactivation by Heparin/Serpin Complexes  Journal Articles
• Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate?  Journal Articles
• Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH  Journal Articles
• Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial  Journal Articles
• Monitoring the anticoagulant effect after a massive rivaroxaban overdose  Journal Articles
• More on Acutely Injured Patients Receiving Dabigatran  Journal Articles
• Morphological analysis of microparticle generation in heparin-induced thrombocytopenia  Journal Articles
• Mortality benefits of thromboprophylaxis  Journal Articles
• Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate  Journal Articles
• Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials  Journal Articles
• Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada  Journal Articles
• Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings  Journal Articles
• Multicentre evaluation of 5B9, a monoclonal anti‐PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology  Journal Articles
• Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia  Journal Articles
• Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee  Journal Articles
• Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation  Journal Articles
• Mutation of Any Site of N-Linked Glycosylation Accelerates the In Vivo Clearance of Recombinant Rabbit Antithrombin  Journal Articles
• Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial  Journal Articles
• NOACs for treatment of venous thromboembolism in clinical practice  Journal Articles
• NOACs only for those who cannot tolerate a VKA: where is the evidence?  Journal Articles
• Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis  Journal Articles
• Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists  Journal Articles
• Navigating the anticoagulant landscape in 2017  Journal Articles
• Need for a new paediatric post thrombotic sequelae outcome measure for non-extremity thrombosis  Journal Articles
• Neonatal Aortic Thrombosis: A Comprehensive Review  Journal Articles
• Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia  Journal Articles
• New Anticoagulant Drugs  Journal Articles
• New Anticoagulant Strategies  Journal Articles
• New Anticoagulant Therapy  Journal Articles
• New Anticoagulants  Journal Articles
• New Anticoagulants  Journal Articles
• New Anticoagulants  Journal Articles
• New Anticoagulants for Atrial Fibrillation  Journal Articles
• New Anticoagulants for Atrial Fibrillation: The Beginning of a A New Era in Stroke Prevention  Journal Articles
• New Anticoagulants for Treatment of Venous Thromboembolism  Journal Articles
• New Anticoagulants for Treatment of Venous Thromboembolism  Journal Articles
• New Anticoagulants for the Prevention of Thromboembolism  Journal Articles
• New Antithrombotic Agents  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New Antithrombotic Drugs: Beyond Aspirin and Heparin  Journal Articles
• New Antithrombotic Drugs: Potential for Use in Oncology  Journal Articles
• New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia  Journal Articles
• New Concepts in Coagulation  Journal Articles
• New Frontiers in the Management of Unstable Coronary Artery Disease  Journal Articles
• New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes  Journal Articles
• New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors  Journal Articles
• New anticoagulant drugs.  Journal Articles
• New anticoagulant strategies.  Journal Articles
• New anticoagulants  Journal Articles
• New anticoagulants  Conferences
• New anticoagulants  Conferences
• New anticoagulants in atrial fibrillation management  Conferences
• New anticoagulants.  Journal Articles
• New anticoagulants: Moving beyond the direct oral anticoagulants  Journal Articles
• New anticoagulants: an update.  Journal Articles
• New anticoagulants: beyond heparin, low‐molecular‐weight heparin and warfarin  Journal Articles
• New antithrombotic agents—insights from clinical trials  Journal Articles
• New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF  Journal Articles
• New aspects on treatment modalities for thromboembolic episodes  Journal Articles
• New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism  Journal Articles
• New developments in anticoagulants: Past, present and future  Journal Articles
• New oral anticoagulant agents – general features and outcomes in subsets of patients  Journal Articles
• New oral anticoagulants and oculoplastic surgery  Journal Articles
• New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions  Journal Articles
• New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty  Journal Articles
• New oral anticoagulants in atrial fibrillation  Journal Articles
• New oral anticoagulants in development  Journal Articles
• New oral anticoagulants in elderly patients  Journal Articles
• New oral anticoagulants versus vitamin K antagonists for treatment of acute venous thromboembolism: do they really increase the incidence of myocardial infarction?  Journal Articles
• New oral anticoagulants: A view from the laboratory  Journal Articles
• New oral anticoagulants: not quite there yet  Journal Articles
• New oral anticoagulants: which one should my patient use?  Journal Articles
• New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010  Journal Articles
• Newer Anticoagulants in Critically Ill Patients  Journal Articles
• Newly Identified Events in the RE-LY Trial  Journal Articles
• News at XI: moving beyond factor Xa inhibitors  Journal Articles
• New‐onset atrial fibrillation in critically ill adult patients—an SSAI clinical practice guideline  Journal Articles
• Ninety‐Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Stroke  Journal Articles
• Non-OO blood type influences the risk of recurrent venous thromboembolism  Journal Articles
• Non-Vitamin K Antagonist Oral Anticoagulants  Journal Articles
• Non-variceal upper gastrointestinal bleeding  Journal Articles
• Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel  Journal Articles
• Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke  Journal Articles
• Nonadherence with INR Monitoring and Anticoagulant Complications  Journal Articles
• Nonbleeding complications of unfractionated and low-molecular weight heparins.  Journal Articles
• Nonhemorrhagic Complications of Anticoagulant Therapy  Journal Articles
• Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia  Journal Articles
• Nonleg Venous Thrombosis in Critically Ill Adults  Conferences
• Nontreatment of deep vein thrombosis.  Journal Articles
• Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment  Journal Articles
• Non–injection‐site necrotic skin lesions complicating postoperative heparin thromboprophylaxis  Journal Articles
• Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study  Journal Articles
• North American Thrombosis Forum, AF Action Initiative Consensus Document  Journal Articles
• North American and British guidelines for anti-thrombotic therapy: are we reaching consensus?  Conferences
• Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study  Journal Articles
• Novel Oral Anticoagulants for Atrial Fibrillation  Journal Articles
• Novel Oral Anticoagulants: A Focused Review for Stroke Physicians  Journal Articles
• Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism  Journal Articles
• Novel anticoagulant agents: introduction  Journal Articles
• Novel antithrombotic strategies for treatment of venous thromboembolism  Journal Articles
• Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants  Journal Articles
• Novel oral anticoagulants and reversal agents: Considerations for clinical development  Journal Articles
• Novel oral anticoagulants in gastroenterology practice  Journal Articles
• Novel oral anticoagulants in secondary prevention of stroke  Journal Articles
• Novel paediatric anticoagulants: a review of the current literature  Journal Articles
• Observations in anticoagulant and thrombolytic therapy in pulmonary embolism  Journal Articles
• Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia  Journal Articles
• Optical Densities Reduce Odds of Heparin-induced Thrombocytopenia Over-diagnosis  Journal Articles
• Optimal Anticoagulation for Pregnant Women with Mechanical Heart Valves  Journal Articles
• Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis  Journal Articles
• Optimal Duration of Anticoagulant Therapy  Journal Articles
• Optimal Duration of Oral Anticoagulant Therapy in Venous Thromboembolism  Journal Articles
• Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis  Journal Articles
• Optimal Therapeutic Range for Oral Anticoagulants  Journal Articles
• Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage  Journal Articles
• Optimal reversal of vitamin K antagonists  Journal Articles
• Optimal therapeutic range for oral anticoagulants.  Journal Articles
• Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeons  Journal Articles
• Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding  Journal Articles
• Optimal treatment duration of venous thrombosis  Journal Articles
• Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants  Journal Articles
• Optimizing warfarin dosing for patients with atrial fibrillation using machine learning  Journal Articles
• Optimum Use of Anticoagulants in Pregnancy  Journal Articles
• Oral Anticoagulant Drugs  Journal Articles
• Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms  Journal Articles
• Oral Anticoagulant Therapy  Journal Articles
• Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis  Journal Articles
• Oral Anticoagulant Therapy in Patients with Coronary Artery Disease  Journal Articles
• Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Cancer  Journal Articles
• Oral Anticoagulant Use and Post-Fall Mortality in Long-Term Care Home Residents.  Journal Articles
• Oral Anticoagulant Use in Patients With Chronic Kidney Disease: How to Choose, and the Importance of Empiric Human Data  Journal Articles
• Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease  Journal Articles
• Oral Anticoagulants  Journal Articles
• Oral Anticoagulants  Journal Articles
• Oral Anticoagulants  Journal Articles
• Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range  Journal Articles
• Oral Anticoagulation Treatment in the Elderly  Journal Articles
• Oral Apixaban for the Treatment of Acute Venous Thromboembolism  Journal Articles
• Oral Direct Factor Xa Inhibitors  Journal Articles
• Oral Rivaroxaban for Symptomatic Venous Thromboembolism  Journal Articles
• Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism  Journal Articles
• Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy  Journal Articles
• Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin  Journal Articles
• Oral anticoagulant dosing, administration, and storage: a cross-sectional survey of Canadian health care providers  Journal Articles
• Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts  Journal Articles
• Oral anticoagulant therapy. Urgent need for standardization.  Journal Articles
• Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives  Journal Articles
• Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF  Journal Articles
• Oral anticoagulants and non-cardioembolic stroke prevention  Journal Articles
• Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Journal Articles
• Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Journal Articles
• Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease  Journal Articles
• Oral anticoagulants in patients with coronary artery disease  Journal Articles
• Oral anticoagulants in patients with coronary artery disease: an inexpensive and effective strategy  Journal Articles
• Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks  Journal Articles
• Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range  Journal Articles
• Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.  Journal Articles
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Journal Articles
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Journal Articles
• Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry  Journal Articles
• Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis  Journal Articles
• Oral anticoagulation for prolonging survival in patients with cancer  Journal Articles
• Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in venous thromboembolism: decisions based on more than mere feelings  Journal Articles
• Oral anticoagulation may prolong survival of a subgroup of patients with cancer: a cochrane systematic review  Journal Articles
• Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial  Journal Articles
• Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis  Journal Articles
• Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement  Journal Articles
• Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement  Journal Articles
• Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10  Journal Articles
• Oral vitamin K for warfarin-associated coagulopathy.  Journal Articles
• Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.  Journal Articles
• Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases  Journal Articles
• Oral-anticoagulant-related intracerebral hemorrhage  Journal Articles
• Orally Active Direct Thrombin Inhibitors  Journal Articles
• Organ Distribution of Fibrin in Disseminated Intravascular Coagulation  Journal Articles
• Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials  Journal Articles
• Otamixaban in acute coronary syndromes  Journal Articles
• Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation  Journal Articles
• Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events  Journal Articles
• Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study  Journal Articles
• Outcomes and predictors of very stable INR control during chronic anticoagulation therapy  Journal Articles
• Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF  Journal Articles
• Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial.  Journal Articles
• Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin  Journal Articles
• Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours  Journal Articles
• Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation  Journal Articles
• Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study  Journal Articles
• Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns  Journal Articles
• Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation  Journal Articles
• Overview of pharmacological interventions after traumatic brain injuries: impact on selected outcomes  Journal Articles
• Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction  Journal Articles
• Overview of the New Oral Anticoagulants  Journal Articles
• PRE‐OPERATIVE FACTOR Xa–TFPI AND POST‐OPERATIVE VENOUS THROMBOSIS  Journal Articles
• PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma  Journal Articles
• Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation  Journal Articles
• Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral Anticoagulation  Journal Articles
• Pancreatic pseudocyst: heparin-induced haemorrhage through the ampulla of Vater.  Journal Articles
• Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial  Journal Articles
• Paper-based dosing algorithms for maintenance of warfarin anticoagulation  Journal Articles
• Parenteral Anticoagulants  Journal Articles
• Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)  Journal Articles
• Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation  Journal Articles
• Parenteral anticoagulation in ambulatory patients with cancer  Journal Articles
• Parenteral anticoagulation in ambulatory patients with cancer  Journal Articles
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review  Journal Articles
• Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence  Journal Articles
• Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline  Journal Articles
• Patient Self-Monitoring of Oral Anticoagulant Therapy  Journal Articles
• Patient education about anticoagulant medication: Is narrative evidence or statistical evidence more effective?  Journal Articles
• Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial  Journal Articles
• Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines  Journal Articles
• Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism  Journal Articles
• Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences  Journal Articles
• Patient-reported health preferences of anticoagulant-related outcomes  Journal Articles
• Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort  Journal Articles
• Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism  Journal Articles
• Patients' perspectives on taking warfarin: qualitative study in family practice  Journal Articles
• Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea  Journal Articles
• Pediatric pulmonary thromboembolism: a 3-year Canadian Pediatric Surveillance Program study  Journal Articles
• Pediatric superior vena cava syndrome: An evidence‐based systematic review of the literature  Journal Articles
• Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management  Journal Articles
• Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation  Journal Articles
• Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopenia  Journal Articles
• Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial  Journal Articles
• Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack  Journal Articles
• Perioperative Anticoagulation for Patients with Mechanical Heart Valves: A Survey of Current Practice  Journal Articles
• Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians  Journal Articles
• Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation  Journal Articles
• Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)  Journal Articles
• Perioperative Management of Anticoagulation  Journal Articles
• Perioperative Management of Antithrombotic Therapy  Journal Articles
• Perioperative Management of Oral Anticoagulation  Journal Articles
• Perioperative Management of Oral Anticoagulation  Journal Articles
• Perioperative Management of Patients Having Noncardiac Surgery Who Are Receiving Anticoagulant or Antiplatelet Therapy: An Evidence-Based but Practical Approach  Journal Articles
• Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach  Journal Articles
• Perioperative Management of Patients Receiving Oral Anticoagulants  Journal Articles
• Perioperative Management of Patients Receiving Oral Anticoagulants  Journal Articles
• Perioperative Management of Patients Taking Direct Oral Anticoagulants  Journal Articles
• Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants  Journal Articles
• Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question  Journal Articles
• Perioperative Management of the Direct Oral Anticoagulants  Journal Articles
• Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials  Journal Articles
• Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide  Journal Articles
• Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.  Journal Articles
• Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians  Journal Articles
• Perioperative anticoagulation—are we at 'a bridge too far'?  Journal Articles
• Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines  Journal Articles
• Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure  Journal Articles
• Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation  Journal Articles
• Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial  Journal Articles
• Perioperative management of anticoagulant and antiplatelet therapy  Journal Articles
• Perioperative management of antithrombotic therapy: a case-based narrative review  Journal Articles
• Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure  Journal Articles
• Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach  Journal Articles
• Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin  Journal Articles
• Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists  Journal Articles
• Periprocedural Management of Direct Oral Anticoagulants  Journal Articles
• Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation  Journal Articles
• Periprocedural Management of Oral Anticoagulation  Journal Articles
• Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants  Journal Articles
• Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy  Journal Articles
• Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy  Journal Articles
• Periprocedural interruption of anticoagulation in patients with cancer‐associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes  Journal Articles
• Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer  Journal Articles
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Journal Articles
• Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH  Journal Articles
• Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation  Journal Articles
• Pharmacogenetics of Antiplatelets and Anticoagulants: A Report on Clopidogrel, Warfarin and Dabigatran  Journal Articles
• Pharmacogenetics of Stroke  Journal Articles
• Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art  Journal Articles
• Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis  Journal Articles
• Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients  Conferences
• Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients  Journal Articles
• Pharmacokinetics of direct oral anticoagulants after bariatric surgery: A retrospective cohort study  Journal Articles
• Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis  Journal Articles
• Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management  Journal Articles
• Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism  Journal Articles
• Pharmacological Actions of Sulodexide  Journal Articles
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research  Journal Articles
• Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis  Journal Articles
• Pharmacology and Clinical Potential of Direct Thrombin Inhibitors  Journal Articles
• Pharmacology and Management of the Vitamin K Antagonists  Journal Articles
• Pharmacology of the low-molecular-weight heparins  Journal Articles
• Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis  Journal Articles
• Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial  Journal Articles
• Pharmacoprophylaxis for Venous Thromboembolism in Spinal Surgery: A Systematic Review and Meta-analysis  Journal Articles
• Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome  Journal Articles
• Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery  Journal Articles
• Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.  Journal Articles
• Pitfalls in the diagnosis of heparin‐Induced thrombocytopenia: A 6‐year experience from a reference laboratory  Journal Articles
• Placental transport of low molecular weight heparin in the pregnant sheep  Journal Articles
• Platelet Activation Testing for Heparin-Induced Thrombocytopenia Antibodies  Journal Articles
• Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review  Journal Articles
• Platelet electrophoresis: effect of defibrination by ancrod (Arvin)  Journal Articles
• Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay  Journal Articles
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Journal Articles
• Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia  Journal Articles
• Polish guidelines for the prevention and treatment of venous thromboembolism 2009 update  Journal Articles
• Polypeptide-Polysaccharide Conjugates Produced by Spontaneous Non-Enzymatic Glycation  Journal Articles
• Polyurethane modified with an antithrombin‐heparin complex via polyethylene oxide linker/spacers: Influence of PEO molecular weight and PEO‐ATH bond on catalytic and direct anticoagulant functions  Journal Articles
• Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?  Journal Articles
• Posthospital discharge venous thromboembolism prophylaxis among colorectal and hepatobiliary surgeons: A practice survey  Journal Articles
• Postoperative Low‐Molecular‐Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators  Journal Articles
• Postoperative atrial fibrillation in non‐cardiac and cardiac surgery: an overview  Journal Articles
• Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial  Journal Articles
• Post‐thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long‐term cross‐sectional follow‐up of RE‐COVER study patients  Journal Articles
• Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months  Journal Articles
• Potential antidotes for reversal of old and new oral anticoagulants  Journal Articles
• Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation  Journal Articles
• Potential of new anticoagulants in patients with cancer  Journal Articles
• Practical aspects of new oral anticoagulant use in atrial fibrillation  Journal Articles
• Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk  Journal Articles
• Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure  Conferences
• Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban  Journal Articles
• Practical management of coagulopathy associated with warfarin  Journal Articles
• Practical management of coagulopathy associated with warfarin.  Journal Articles
• Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung  Journal Articles
• Pre-Screening for Atrial Fibrillation Using the Electronic Health Record  Journal Articles
• Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy  Journal Articles
• Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)  Journal Articles
• Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation  Journal Articles
• Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism  Journal Articles
• Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment  Journal Articles
• Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol  Journal Articles
• Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis  Journal Articles
• Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF  Journal Articles
• Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial  Journal Articles
• Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA)  Journal Articles
• Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol  Journal Articles
• Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial  Journal Articles
• Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency  Journal Articles
• Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure  Journal Articles
• Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis  Journal Articles
• Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001  Journal Articles
• Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery: A Prospective Cohort Study  Journal Articles
• Preface  Journal Articles
• Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making  Journal Articles
• Pregnancy, Heparin and Osteoporosis  Journal Articles
• Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment  Journal Articles
• Preoperative antithrombin supplementation in cardiac surgery: A randomized controlled trial  Journal Articles
• Pretreatment of Rabbits With Either Hirudin, Ancrod, or Warfarin Significantly Reduces the Immediate Uptake of Fibrinogen and Platelets by the Deendothelialized Aorta Wall After Balloon-Catheter Injury In Vivo  Journal Articles
• Prevalence and Management of Atrial Thrombi in Patients With Atrial Fibrillation Before Pulmonary Vein Isolation  Journal Articles
• Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE  Journal Articles
• Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study  Journal Articles
• Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries  Journal Articles
• Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation  Journal Articles
• Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran  Journal Articles
• Preventing Thromboembolism in Patients with Prosthetic Heart Valves  Journal Articles
• Preventing and managing bleeding complications in anticoagulated patients: A case based approach  Journal Articles
• Preventing thrombophilia-related complications of pregnancy  Journal Articles
• Preventing thrombophilia-related complications of pregnancy: an update  Journal Articles
• Prevention and Treatment of Hormone-Associated Venous Thromboembolism: A Patient Management Approach  Journal Articles
• Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey  Journal Articles
• Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention  Journal Articles
• Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment  Journal Articles
• Prevention and treatment of venous thromboembolism during pregnancy  Journal Articles
• Prevention and treatment of venous thromboembolism in the elderly patient.  Journal Articles
• Prevention of Postthrombotic Syndrome  Journal Articles
• Prevention of Thromboembolic Events After Bioprosthetic Aortic Valve Replacement  Journal Articles
• Prevention of Thrombosis in Ambulatory Patients With Cancer  Journal Articles
• Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy  Journal Articles
• Prevention of Venous Thromboembolism  Journal Articles
• Prevention of Venous Thromboembolism  Journal Articles
• Prevention of Venous Thromboembolism  Journal Articles
• Prevention of Venous Thromboembolism After Hip or Knee Arthroplasty  Journal Articles
• Prevention of Venous Thromboembolism Among Hospitalized Medical Patients  Journal Articles
• Prevention of Venous Thrombosis After Elective Hip Surgery  Journal Articles
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Journal Articles
• Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone  Journal Articles
• Prevention of deep venous thrombosis.  Journal Articles
• Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review  Journal Articles
• Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation  Journal Articles
• Prevention of vascular complications after cerebral ischaemia of arterial organ; the ESPRIT study: mild anticoagulant therapy, combination treatment with acetylsalicylic acid and dipyridamole, or treatment with acetylsalicylic acid alone?  Journal Articles
• Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study  Journal Articles
• Prevention of venous thromboembolism in critically ill surgery patients: A cross-sectional study  Journal Articles
• Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions  Journal Articles
• Prevention of venous thromboembolism in medical cancer patients: Guidance or guideline?  Journal Articles
• Prevention of venous thromboembolism in medical patients with enoxaparin  Journal Articles
• Prevention of venous thromboembolism in medically ill patients: a clinical update  Journal Articles
• Prevention of venous thrombosis after electrophysiology procedures: a survey of national practice  Journal Articles
• Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures.  Journal Articles
• Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care.  Journal Articles
• Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke  Journal Articles
• Principles and practice of coronary thrombolysis and conjunctive treatment  Journal Articles
• Principles for management of hip fracture for older adults taking direct oral anticoagulants: an international consensus statement  Journal Articles
• Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants  Journal Articles
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Journal Articles
• Probable regulation of factor VIIa–tissue factor and prothrombinase by factor Xa–TFPI and TFPI in vivo  Journal Articles
• Proceedings of the 12th national conference on anticoagulant therapy  Journal Articles
• Procoagulants for management of bleeding with the new oral anticoagulants  Journal Articles
• Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study  Journal Articles
• Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study  Journal Articles
• Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study  Journal Articles
• Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation  Journal Articles
• Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients—A Systematic Review and Meta-Analysis  Journal Articles
• Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)  Journal Articles
• Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran  Journal Articles
• Prognostic importance of preoperative anti-PF4/heparin antibodies in patients undergoing cardiac surgery  Journal Articles
• Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis  Journal Articles
• Progressive thrombocytopenia after cardiac surgery in a 67-year-old man  Journal Articles
• Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins  Journal Articles
• Prolonged Cardiac Monitoring and Stroke Recurrence  Journal Articles
• Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials  Journal Articles
• Prolonged in vivo anticoagulant activity of a hirudin–albumin fusion protein secreted from Pichia pastoris  Journal Articles
• Promoting the health of senior citizens.  Journal Articles
• Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>  Journal Articles
• Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence‑based and practical approach  Journal Articles
• Prophylaxis against venous thromboembolism in neurointensive care patients: Survey of Canadian practice  Journal Articles
• Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.  Journal Articles
• Prophylaxis extension for venous thromboembolism after major abdominal and pelvic surgery for cancer (prevent): Quality improvement transitioned into a cohort study  Journal Articles
• Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study  Journal Articles
• Prophylaxis of Venous Thromboembolism  Journal Articles
• Prophylaxis of venous thromboembolism. An overview.  Journal Articles
• Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation  Journal Articles
• Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia  Journal Articles
• Prospective multicentre cohort study of heparin‐induced thrombocytopenia in acute ischaemic stroke patients  Journal Articles
• Prosthetic Heart Valve Thrombosis  Journal Articles
• Protamine (heparin)‐induced thrombocytopenia: a review of the serological and clinical features associated with anti‐protamine/heparin antibodies  Journal Articles
• Protein C Assay Performance  Journal Articles
• Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non–vitamin K Anticoagulant Reversal  Journal Articles
• Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate  Journal Articles
• Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis  Journal Articles
• Prothrombotic genetic risk factors and heparin-induced thrombocytopenia  Journal Articles
• Protocol implementation for venous thromboembolism prophylaxis: a before-and-after study in medical and surgical patients  Journal Articles
• Präoperative Bewertung des Blutungs- und Thromboseembolierisikos  Journal Articles
• Prévention des complications vasculaires après ischémie cérébrale d'origine artérielle. Étude ESPRIT: anticoagulation modérée, association aspirine-dipyridamole ou aspirine seule ?  Journal Articles
• Pseudothrombocytopenia Due to Platelet Aggregation and Degranulation in Blood Collected in EDTA  Journal Articles
• Pulmonary Embolism With Duplicated Inferior Vena Cava  Journal Articles
• Pulmonary Embolism in Medical-Surgical Critically Ill Patients  Journal Articles
• Pulmonary Embolism in Pregnancy  Journal Articles
• Pulmonary Embolism in the Elderly  Journal Articles
• Putting heparin into perspective: its history and the evolution of its use during percutaneous coronary interventions.  Journal Articles
• Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm  Journal Articles
• Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry  Journal Articles
• Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study  Journal Articles
• Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review  Journal Articles
• Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study  Journal Articles
• Quality of oral anticoagulant control and treatment in Sweden  Journal Articles
• Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group.  Journal Articles
• Questioning the Treatment of Venous Thromboembolism  Journal Articles
• RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT  Journal Articles
• RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate  Journal Articles
• Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol  Journal Articles
• Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy  Journal Articles
• Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation  Journal Articles
• Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism  Journal Articles
• Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer  Journal Articles
• Randomized Trial of Warfarin Nomograms  Journal Articles
• Randomized Trial of Warfarin Nomograms  Journal Articles
• Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)  Journal Articles
• Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation  Journal Articles
• Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis  Journal Articles
• Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study  Journal Articles
• Randomized trial of warfarin nomograms.  Journal Articles
• Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention  Journal Articles
• Randomized, Controlled Trial of Individualized Heparin and Protamine Management in Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass  Journal Articles
• Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients  Journal Articles
• Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]  Journal Articles
• Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study  Journal Articles
• Rapid reversal of haematoma expansion associated with vitamin K antagonists  Journal Articles
• Rare inherited coagulation and fibrinolytic defects that challenge diagnostic laboratories  Journal Articles
• Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation  Journal Articles
• Rates of hemorrhage during warfarin therapy for atrial fibrillation  Journal Articles
• Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding  Journal Articles
• Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran  Journal Articles
• Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery  Journal Articles
• Rationale and design of a Global Rheumatic Heart Disease Registry: The REMEDY study  Journal Articles
• Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis  Journal Articles
• Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial  Journal Articles
• Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial  Journal Articles
• Re: Anticoagulation and Antiplatelet Therapy in Urological Practice: ICUD/AUA Review Paper: D. J. Culkin, E. J. Exaire, D. Green, M. S. Soloway, A. J. Gross, M. R. Desai, J. R. White and D. J. Lightner J Urol 2014; 192: 1026-1034  Journal Articles
• Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.  Journal Articles
• Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial  Journal Articles
• Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens  Journal Articles
• Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial  Journal Articles
• Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent  Journal Articles
• Recent Advances in Thrombosis and Hemostasis – Part I  Journal Articles
• Recent advances in understanding, diagnosing and treating venous thrombosis  Journal Articles
• Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins  Journal Articles
• Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update  Journal Articles
• Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation  Journal Articles
• Recommendations for developing uniform laboratory monitoring of heparinoid anticoagulants in children  Journal Articles
• Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH  Journal Articles
• Recommendations from the ICM-VTE: General  Journal Articles
• Recommendations from the ICM-VTE: Oncology  Journal Articles
• Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis  Journal Articles
• Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?  Journal Articles
• Recurrent Venous Thrombosis and Heparin Therapy  Journal Articles
• Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation  Journal Articles
• Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta‐analysis  Journal Articles
• Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis  Journal Articles
• Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study  Journal Articles
• Reduced-Intensity Anticoagulation for Mechanical Aortic Valve Prostheses  Journal Articles
• Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial  Journal Articles
• Reduced‐dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta‐analysis—Response to Commentary  Journal Articles
• Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis  Journal Articles
• Reducing the risk of recurrent stroke in patients with AF  Journal Articles
• Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis  Journal Articles
• Refining Risk Prediction for Recurrent Venous Thromboembolism: Can We Do Better?  Journal Articles
• Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure  Journal Articles
• Relationship Between Thromboembolic Complications and Intensity of Treatment During Long-Term Prophylaxis with Oral Anticoagulants Following DVT  Journal Articles
• Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes  Journal Articles
• Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis  Journal Articles
• Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin  Journal Articles
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin  Journal Articles
• Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio  Journal Articles
• Reply to Left Atrial Appendage Closure During Cardiac Surgery for Atrial Fibrillation: A Meta-Analysis  Journal Articles
• Reply to Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism  Journal Articles
• Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care  Journal Articles
• Reply to Xu—Oral Anticoagulants, Health Technology Assessment, and Health Policy  Journal Articles
• Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis?  Journal Articles
• Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban  Journal Articles
• Research agenda: venous thromboembolism in medical-surgical critically ill patients  Journal Articles
• Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.  Journal Articles
• Residual Vein Thrombosis and D-Dimer for Optimizing Duration of Anticoagulation in Idiopathic Deep Vein Thrombosis  Journal Articles
• Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study  Journal Articles
• Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study  Journal Articles
• Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study  Journal Articles
• Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study  Journal Articles
• Resolving Concerns With the Newer Oral Anticoagulant Medications  Journal Articles
• Resource Use and Costs of Treatment With Anticoagulation and Antiplatelet Agents: Results of the WATCH Trial Economic Evaluation  Journal Articles
• Response by Chan and Weitz to Letter Regarding Article, “Antithrombotic Agents: New Directions in Antithrombotic Therapy”  Journal Articles
• Response by McIntyre et al to Letter Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials".  Journal Articles
• Response by Weitz and Eikelboom to Letter Regarding Article, “Urgent Need to Measure Effects of Direct Oral Anticoagulants”  Journal Articles
• Response to Letter Regarding Article, “Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy”  Journal Articles
• Response to Letter Regarding Article, “Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study”  Journal Articles
• Response to Letters Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”  Journal Articles
• Response to letter: non‐vitamin‐K oral anticoagulants may not significantly reduce the risk of fatal or disabling stroke compared with warfarin  Journal Articles
• Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.  Journal Articles
• Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban”  Journal Articles
• Response.  Journal Articles
• Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation  Journal Articles
• Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches  Journal Articles
• Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality  Journal Articles
• Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage  Journal Articles
• Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis  Journal Articles
• Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management  Journal Articles
• Reversal agents for current and forthcoming direct oral anticoagulants  Journal Articles
• Reversal agents for non-vitamin K antagonist oral anticoagulants  Journal Articles
• Reversal of Direct Oral Anticoagulants: Current Status and Future Directions  Journal Articles
• Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies  Journal Articles
• Reversal of Warfarin  Journal Articles
• Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum  Journal Articles
• Reversal of direct oral anticoagulants: a practical approach  Journal Articles
• Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH  Journal Articles
• Reversal of target-specific oral anticoagulants  Journal Articles
• Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1  Journal Articles
• Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice  Journal Articles
• Reversible endotension associated with excessive warfarin anticoagulation  Journal Articles
• Reversing Anticoagulant Therapy  Journal Articles
• Reversing anticoagulants both old and new.  Journal Articles
• Review of enoxaparin and its clinical applications in venous and arterial thromboembolism  Journal Articles
• Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding  Journal Articles
• Review: New oral anticoagulants increase GI bleeding in venous thrombosis and ACS  Journal Articles
• Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation  Journal Articles
• Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit  Journal Articles
• Reviparin in Acute Myocardial Infarction—Reply  Journal Articles
• Reviparin in acute myocardial infarction.  Journal Articles
• Right-sided endocarditis secondary to a peritoneovenous shunt  Journal Articles
• Risk Assessment and Primary VTE Prevention in the Cancer Patient  Journal Articles
• Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness  Journal Articles
• Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit)  Journal Articles
• Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review  Journal Articles
• Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial  Journal Articles
• Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis  Journal Articles
• Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial  Journal Articles
• Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation  Journal Articles
• Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban  Journal Articles
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials  Journal Articles
• Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment  Journal Articles
• Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation  Journal Articles
• Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound  Journal Articles
• Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism  Journal Articles
• Risk of Haemorrhage Associated with Long Term Anticoagulant Therapy  Journal Articles
• Risk of Intracranial Hemorrhage Associated With Direct Oral Anticoagulation vs Antiplatelet Therapy: A Systematic Review and Meta-Analysis.  Journal Articles
• Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding  Journal Articles
• Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin  Journal Articles
• Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal  Journal Articles
• Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trials  Journal Articles
• Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis  Journal Articles
• Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study  Journal Articles
• Risk of mortality and stroke after atrial fibrillation – Authors' reply  Journal Articles
• Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study  Journal Articles
• Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis  Journal Articles
• Risk of recurrent venous thromboembolism after a first oestrogen-associated episode  Journal Articles
• Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting  Journal Articles
• Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism  Journal Articles
• Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage  Journal Articles
• Risks and Benefits of Anticoagulant Therapy  Journal Articles
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Journal Articles
• Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry  Journal Articles
• Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial  Journal Articles
• Risks to the Fetus of Anticoagulant Therapy During Pregnancy  Journal Articles
• Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios  Journal Articles
• Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro  Journal Articles
• Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography  Journal Articles
• Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial  Journal Articles
• Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions  Journal Articles
• Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older  Journal Articles
• Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial  Journal Articles
• Rivaroxaban for the prevention and treatment of venous thromboembolism  Journal Articles
• Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation  Journal Articles
• Rivaroxaban for treatment of suspected or confirmed heparin‐induced thrombocytopenia study  Journal Articles
• Rivaroxaban in Orthopedic Surgery — A Change of Paradigm?  Journal Articles
• Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation  Journal Articles
• Rivaroxaban in Stable Cardiovascular Disease  Journal Articles
• Rivaroxaban in treatment refractory heparin-induced thrombocytopenia  Journal Articles
• Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty  Journal Articles
• Rivaroxaban versus enoxaparin after total knee arthroplasty  Journal Articles
• Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial  Journal Articles
• Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study  Journal Articles
• Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease  Journal Articles
• Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients  Journal Articles
• Routine home treatment of deep vein thrombosis  Journal Articles
• Routine home treatment of deep vein thrombosis - Is now a reality  Journal Articles
• Routine measurement of DOAC concentrations for prognostication and clinical management in acute ischemic stroke: Is it ready for prime time?  Journal Articles
• SR123781A: A New Once-Daily Synthetic Oligosaccharide Anticoagulant for Thromboprophylaxis After Total Hip Replacement Surgery  Journal Articles
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Journal Articles
• Safer anticoagulant therapy after heart valve replacement  Journal Articles
• Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis  Journal Articles
• Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure  Journal Articles
• Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism  Journal Articles
• Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study  Journal Articles
• Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)  Journal Articles
• Safety of Uninterrupted Anticoagulation in Patients Requiring Elective Coronary Angiography With or Without Percutaneous Coronary Intervention  Journal Articles
• Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism  Journal Articles
• Safety of anticoagulants in children with arterial ischemic stroke  Journal Articles
• Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists  Journal Articles
• Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging  Journal Articles
• Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk  Journal Articles
• Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19  Journal Articles
• Scoring systems for heparin-induced thrombocytopenia (HIT): Whither now?  Journal Articles
• Screening for Atrial Fibrillation in the Older Population  Journal Articles
• Screening for undiagnosed atrial fibrillation  Journal Articles
• Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation  Journal Articles
• Second-Order Peer Reviews of Clinically Relevant Articles for the Physiatrist  Journal Articles
• Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran  Journal Articles
• Secondary prevention of venous thromboembolism  Journal Articles
• Secondary stroke prevention in people with atrial fibrillation: treatments and trials  Journal Articles
• Sekundärprävention nach ischämischem zerebralem Insult  Journal Articles
• Selection Bias, Orthopaedic Style  Journal Articles
• Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis  Journal Articles
• Selective cleavage of heparin using aqueous 2-hydroxypyridine: Production of an aldose-terminating fragment with high anticoagulant activity  Journal Articles
• Selective factor Xa inhibition for thromboprophylaxis  Journal Articles
• Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review  Journal Articles
• Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study  Journal Articles
• Serial measurement of interleukin‐6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE‐LY trials  Journal Articles
• Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: HIT or not HIT?  Journal Articles
• Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE  Journal Articles
• Setting a standard for venous thromboembolism prophylaxis  Journal Articles
• Sex differences in thromboprophylaxis of the critically ill: a secondary analysis of a randomized trial  Journal Articles
• Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen?  Journal Articles
• Short report: managing anticoagulation. Comparison of results at three primary care centres.  Journal Articles
• Short- and Long-term Health Care Resource Utilization and Costs Following Intracerebral Hemorrhage  Journal Articles
• Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement  Journal Articles
• Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial  Journal Articles
• Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis  Journal Articles
• Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?  Journal Articles
• Should adult patients be routinely tested for heritable thrombophilia after an episode of venous thromboembolism?  Journal Articles
• Should the presence of an antiphospholipid antibody affect the duration of anticoagulant treatment in patients with venous thromboembolism?  Journal Articles
• Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation  Journal Articles
• Should vitamin K be administered when HIT is diagnosed after administration of coumarin?  Journal Articles
• Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?  Journal Articles
• Side-Effects of COVID-19 on Patient Care: An INR Story  Journal Articles
• Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation  Journal Articles
• Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up  Journal Articles
• Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin  Journal Articles
• Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range  Journal Articles
• Small intestinal bacterial overgrowth and warfarin dose requirement variability  Journal Articles
• So, Does Low-Molecular-Weight Heparin Cause Less Heparin-Induced Thrombocytopenia Than Unfractionated Heparin or Not?  Journal Articles
• Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study  Journal Articles
• Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective  Journal Articles
• Special series on challenging anticoagulation cases: Experience counts when guidelines fall short  Journal Articles
• Specific antidotes for bleeding associated with direct oral anticoagulants  Journal Articles
• Splanchnic vein thrombosis: what are the long-term risks?  Journal Articles
• Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia  Journal Articles
• Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder  Journal Articles
• Spontaneous neonatal arterial thromboembolism  Journal Articles
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials  Journal Articles
• State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism  Journal Articles
• Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial  Journal Articles
• Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial  Journal Articles
• Stroke Prenotification Is Associated with Shorter Treatment Times for Warfarin-Associated Intracerebral Hemorrhage  Journal Articles
• Stroke Prevention in Atrial Fibrillation  Journal Articles
• Stroke Prevention in Atrial Fibrillation  Journal Articles
• Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease  Journal Articles
• Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Journal Articles
• Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation  Journal Articles
• Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?  Journal Articles
• Stroke and Thromboprophylaxis in the Era of COVID-19  Journal Articles
• Stroke prevention for patients with atrial fibrillation: values and preferences of Canadian emergency medicine trainees  Journal Articles
• Stroke prevention in atrial fibrillation: Closing the gap  Journal Articles
• Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes  Journal Articles
• Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation  Journal Articles
• Stroke prevention in older adults with atrial fibrillation  Journal Articles
• Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry  Journal Articles
• Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease  Journal Articles
• Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program  Journal Articles
• Structure and function of a perioperative anticoagulation management clinic  Journal Articles
• Studies of the anti–platelet factor 4/heparin immune response: adapting the enzyme‐linked immunosorbent spot assay for detection of memory B cells against complex antigens  Journal Articles
• Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis  Journal Articles
• Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective  Journal Articles
• Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin  Journal Articles
• Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose  Journal Articles
• Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial  Journal Articles
• Sub‐segmental pulmonary embolism in three academic teaching hospitals: a review of management and outcomes  Journal Articles
• Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials  Journal Articles
• Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis  Journal Articles
• Surface modification with an antithrombin–heparin complex for anticoagulation: Studies on a model surface with gold as substrate  Journal Articles
• Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.  Journal Articles
• Survey of pharmacologic thromboprophylaxis in critically ill children*  Journal Articles
• Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update  Journal Articles
• Switching Patients From Blinded Study Drug to Warfarin at the End of the ENGAGE AF–TIMI 48 Trial  Journal Articles
• Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis  Journal Articles
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Journal Articles
• Systematic Overview of Warfarin and Its Drug and Food Interactions  Journal Articles
• Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants  Journal Articles
• Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism  Journal Articles
• Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper-Gastrointestinal and Hepatopancreatobiliary Surgery  Journal Articles
• Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer  Journal Articles
• Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis  Journal Articles
• Systematic review of anticoagulant treatment of catheter-related thrombosis  Journal Articles
• Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale  Journal Articles
• Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology  Journal Articles
• THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY  Journal Articles
• TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol  Journal Articles
• Tailoring warfarin induction doses to reflect individual and disease-specific factors  Journal Articles
• Temporal Aspects of Heparin-Induced Thrombocytopenia  Journal Articles
• Temporal Trends in Prevention of Venous Thromboembolism Following Primary Total Hip or Knee Arthroplasty 1996–2001  Journal Articles
• Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.  Journal Articles
• Testing for Heparin-Induced Thrombocytopenia Antibodies  Journal Articles
• The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal  Journal Articles
• The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation  Journal Articles
• The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients  Journal Articles
• The APTT Response of Pregnant Plasma to Unfractionated Heparin  Journal Articles
• The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate  Journal Articles
• The Approach to Heparin-Induced Thrombocytopenia  Journal Articles
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Journal Articles
• The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?  Journal Articles
• The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED)  Journal Articles
• The Clinical Utility of a Rapid Bedside D-dimer Assay for Screening of Deep Vein Thrombosis following Orthopaedic Surgery  Journal Articles
• The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty  Journal Articles
• The Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation  Journal Articles
• The Diagnosis and Management of Ovarian Hyperstimulation Syndrome  Journal Articles
• The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism  Journal Articles
• The Duration of Oral Anticoagulation after Deep Vein Thrombosis  Journal Articles
• The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes  Journal Articles
• The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial  Journal Articles
• The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density  Journal Articles
• The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis  Journal Articles
• The Efficacy and Safety of Heparin in Patients With Sepsis  Journal Articles
• The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia  Journal Articles
• The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population  Journal Articles
• The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations  Journal Articles
• The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion  Journal Articles
• The Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty  Journal Articles
• The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle>  Conferences
• The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis  Conferences
• The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War?  Journal Articles
• The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE  Journal Articles
• The New Canadian Cardiovascular Society Algorithm for Antithrombotic Therapy of Atrial Fibrillation Is Appropriately Based on Current Epidemiologic Data  Journal Articles
• The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations  Journal Articles
• The Occurrence of Subsequent Malignancy in Patients Presenting with Deep Vein Thrombosis: Results from a Historical Cohort Study  Journal Articles
• The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial  Journal Articles
• The Optimal Duration of Anticoagulant Therapy for Venous Thrombosis  Journal Articles
• The Oral Thrombin Inhibitor Dabigatran: Strengths and Weaknesses  Journal Articles
• The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina  Journal Articles
• The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia  Journal Articles
• The Pathophysiology of Heparin-Induced Thrombocytopenia  Journal Articles
• The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale  Journal Articles
• The Pharmacology and Management of the Vitamin K Antagonists  Journal Articles
• The Real Decoy  Journal Articles
• The Risk Factors for Thromboembolism in Nonvalvular Atrial Fibrillation and CHADS2 Scoring in Japan  Journal Articles
• The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism  Journal Articles
• The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy  Journal Articles
• The Role for Optical Density in Heparin-Induced Thrombocytopenia  Journal Articles
• The Role of Ximelagatran in the Treatment of Venous Thromboembolism  Journal Articles
• The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism: Outpatient versus inpatient management  Journal Articles
• The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers  Journal Articles
• The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients  Journal Articles
• The Significance of Hypofibrinolysis for the Risk of Recurrence of Venous Thromboembolism  Journal Articles
• The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants  Journal Articles
• The Ten Most Commonly Asked Questions about Chronic Anticoagulant Use in Cardiology  Journal Articles
• The United States Food and Drugs Administration Approves a Generic Enoxaparin  Journal Articles
• The Vagus Nerve: A Tonic Inhibitory Influence Associated With Inflammatory Bowel Disease in a Murine Model  Journal Articles
• The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics  Journal Articles
• The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal  Journal Articles
• The anticoagulant action of puff adder (B. arietans) venom.  Journal Articles
• The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation  Journal Articles
• The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study  Journal Articles
• The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events  Journal Articles
• The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation  Journal Articles
• The beginning of the end of warfarin?  Journal Articles
• The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem  Journal Articles
• The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients  Journal Articles
• The clinical impact of bleeding during oral anticoagulant therapy  Journal Articles
• The conundrum of resuming anticoagulant therapy after intracerebral bleeding: In whom, when, and how?  Journal Articles
• The cost‐effectiveness of computer‐assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study  Journal Articles
• The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery  Journal Articles
• The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring  Journal Articles
• The diagnosis and prevention of post operative venous thrombosis.  Journal Articles
• The diagnosis and treatment of thrombosis in the cancer patient.  Journal Articles
• The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.  Journal Articles
• The direct thrombin inhibitor hirudin  Journal Articles
• The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin  Journal Articles
• The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group.  Journal Articles
• The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass  Journal Articles
• The effects of oral anticoagulants in patients with peripheral arterial disease: Rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials  Journal Articles
• The effects of rivaroxaban on the complications of surgery after total hip or knee replacement  Journal Articles
• The emerging role of low-molecular-weight heparin in cardiovascular medicine  Journal Articles
• The endocarditis that was not: an unusual case of heparin-induced thrombocytopenia with unusual complications.  Journal Articles
• The hazards of interrupting anticoagulation therapy in atrial fibrillation  Journal Articles
• The historical origins of modern international normalized ratio targets  Journal Articles
• The identification of at‐risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH  Journal Articles
• The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis  Journal Articles
• The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate  Journal Articles
• The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review  Journal Articles
• The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE  Journal Articles
• The international normalized ratio. A guide to understanding and correcting its problems  Journal Articles
• The management of anticoagulated patients requiring dental extraction: a cross‐sectional survey of oral and maxillofacial surgeons and hematologists  Journal Articles
• The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians  Journal Articles
• The new oral anticoagulants  Journal Articles
• The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study  Journal Articles
• The optimal intensity of oral anticoagulant therapy  Journal Articles
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Journal Articles
• The paradox of heparin‐induced thrombocytopenia  Journal Articles
• The prognostic utility of ICH-score in anticoagulant related intracerebral hemorrhage  Journal Articles
• The proteolytic action of Arvin on human fibrinogen  Journal Articles
• The proteolytic action of arvin on human fibrinogen  Journal Articles
• The reemergence of aspirin for the prevention of venous thromboembolism.  Journal Articles
• The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.  Journal Articles
• The risk and prevention of venous thromboembolism in the pregnant traveller  Journal Articles
• The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism  Journal Articles
• The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia  Journal Articles
• The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding  Journal Articles
• The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial  Journal Articles
• The safety of antithrombotic therapy during pregnancy  Journal Articles
• The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: Assessment of a standardized patient management protocol  Journal Articles
• The safety of fondaparinux for the prevention and treatment of venous thromboembolism  Journal Articles
• The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia  Journal Articles
• The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group.  Journal Articles
• The significance of new onset atrial fibrillation complicating acute myocardial infarction  Journal Articles
• The status of new anticoagulants  Journal Articles
• The top 4 advances in antithrombotic care in the last year  Journal Articles
• The treatment of venous thromboembolism.  Journal Articles
• The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis  Journal Articles
• The use of low molecular weight heparin in pediatric patients: A prospective cohort study  Journal Articles
• The use of low molecular weight heparins in pediatrics: Two cases that highlight potential risks to patient safety  Journal Articles
• The use of the evacuated blood collection tube in the determination of plasma betathromboglobulin  Journal Articles
• The use of well‐characterized sera for the assessment of new diagnostic enzyme‐immunoassays for the diagnosis of heparin‐induced thrombocytopenia  Journal Articles
• The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive value  Journal Articles
• The value of novel oral anticoagulants in rural Australia  Journal Articles
• The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance  Journal Articles
• The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation  Journal Articles
• The worcester venous thromboembolism study  Journal Articles
• The “parallel-cohort RCT”: Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism  Journal Articles
• Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19  Journal Articles
• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19  Journal Articles
• Therapeutic Range for the Control of Oral Anticoagulant Therapy  Journal Articles
• Therapeutic strategies for thrombosis: new targets and approaches  Journal Articles
• Therapy of deep vein thrombosis.  Journal Articles
• Therapy of unstable angina with the low molecular weight heparins  Journal Articles
• There seems to be no benefit from using ε-aminocaproic acid in addition to routine postextraction advice in patients receiving anticoagulation therapy  Journal Articles
• Think of HIT When Thrombosis Follows Heparin  Journal Articles
• Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared With Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Thoracoscopic Left Atrial Appendage Occlusion  Journal Articles
• Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis  Journal Articles
• Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers  Journal Articles
• Thrombin activation rate constant: One-stage chromogenic assay for the extrinsic system  Journal Articles
• Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes  Journal Articles
• Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature  Journal Articles
• Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis  Journal Articles
• Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])  Journal Articles
• Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study  Conferences
• Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art  Journal Articles
• Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants  Journal Articles
• Thromboembolic complications in children with cancer  Journal Articles
• Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management  Journal Articles
• Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding  Journal Articles
• Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum  Journal Articles
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.  Journal Articles
• Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy  Journal Articles
• Thromboembolism and anticoagulant management in hemodialysis patients: A practical guide to clinical management  Journal Articles
• Thromboembolism and pregnancy.  Journal Articles
• Thromboembolism in Infants and Children With Gastrointestinal Failure Receiving Long‐Term Parenteral Nutrition  Journal Articles
• Thromboembolism in children with sarcoma  Journal Articles
• Thromboembolism prevention in ischaemic stroke  Journal Articles
• Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism  Journal Articles
• Thrombolysis by chemically modified coagulation factor Xa  Journal Articles
• Thrombolytic Therapy for Submassive Pulmonary Embolism?  Journal Articles
• Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?  Journal Articles
• Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis  Journal Articles
• Thrombophilia and New Anticoagulant Drugs  Journal Articles
• Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ?  Journal Articles
• Thromboprophylaxis After Hip or Knee Arthroplasty  Journal Articles
• Thromboprophylaxis after Knee Arthroscopy  Journal Articles
• Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis  Journal Articles
• Thromboprophylaxis during chemotherapy: NO  Journal Articles
• Thromboprophylaxis for hospitalized medical patients: A Multicenter Qualitative study  Journal Articles
• Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis  Journal Articles
• Thromboprophylaxis in Patients with Acute Spinal Cord Injury: A Narrative Review  Journal Articles
• Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin  Journal Articles
• Thromboprophylaxis in medical-surgical intensive care unit patients  Journal Articles
• Thromboprophylaxis in paediatric acute lymphoblastic leukaemia  Journal Articles
• Thromboprophylaxis in surgical patients.  Journal Articles
• Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients  Journal Articles
• Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit  Journal Articles
• Thromboprophylaxis practice patterns in hip fracture surgery patients: experience in Perth, Western Australia  Journal Articles
• Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.  Journal Articles
• Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials  Journal Articles
• Thromboprophylaxis with dalteparin in medical patients: which patients benefit?  Journal Articles
• Thrombosis and anticoagulation in the setting of renal or liver disease  Journal Articles
• Thrombosis and anticoagulation.  Journal Articles
• Thrombosis and embolism in pediatric cardiomyopathy  Journal Articles
• Thrombosis in Children  Journal Articles
• Thrombosis in pregnancy  Journal Articles
• Thrombosis of the Cerebral Veins and Sinuses  Journal Articles
• Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial  Journal Articles
• Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart Palliation  Journal Articles
• Thrombotic Complications of Neonates and Children with Congenital Nephrotic Syndrome  Journal Articles
• Thrombotic Disorders: Diagnosis and Treatment  Journal Articles
• Thrombotic End Point for Assessing Argatroban Therapy for Heparin-Induced Thrombocytopenia  Journal Articles
• Thrombotic Risk in the Antiphospholipid Syndrome  Journal Articles
• Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer  Journal Articles
• Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice.  Journal Articles
• Timing of Major Postoperative Bleeding Among Patients Undergoing Surgery  Journal Articles
• Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin  Journal Articles
• Timing of symptomatic venous thromboembolism after surgery: meta-analysis  Journal Articles
• Timing the First Postoperative Dose of Anticoagulants  Journal Articles
• To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections  Journal Articles
• To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment  Journal Articles
• Tossing a coin or using common sense  Journal Articles
• Transesophageal echocardiography in patients with cryptogenic ischemic stroke: A systematic review  Journal Articles
• Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.  Journal Articles
• Transient Global Amnesia as the Presenting Feature of Heparin-Induced Thrombocytopenia  Journal Articles
• Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism  Journal Articles
• Translational Success Stories  Journal Articles
• Treatment Algorithm in Cancer-Associated Thrombosis: Canadian Expert Consensus  Journal Articles
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Journal Articles
• Treatment and prophylaxis of venous thromboembolism during pregnancy  Journal Articles
• Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis  Journal Articles
• Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction  Journal Articles
• Treatment of Deep-Vein Thrombosis  Journal Articles
• Treatment of First Episode of Venous Thrombosis  Journal Articles
• Treatment of Heparin-Induced Thrombocytopenia  Journal Articles
• Treatment of Proximal Deep Vein Thrombosis With a Novel Synthetic Compound (SR90107A/ORG31540) With Pure Anti–Factor Xa Activity  Journal Articles
• Treatment of Venous Thromboembolism  Journal Articles
• Treatment of Venous Thromboembolism in Cancer Patients  Journal Articles
• Treatment of Venous Thromboembolism in Cancer Patients  Journal Articles
• Treatment of Venous Thromboembolism in Cancer Patients  Journal Articles
• Treatment of Venous Thromboembolism with New Oral Anticoagulants According to Patient Risk  Journal Articles
• Treatment of Venous Thrombosis in the Cancer Patient  Journal Articles
• Treatment of acute pulmonary embolism with dabigatran versus warfarin  Journal Articles
• Treatment of bleeding complications in patients on anticoagulant therapy  Journal Articles
• Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management  Journal Articles
• Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m)  Journal Articles
• Treatment of deep vein thrombosis: what factors determine appropriate treatment?  Journal Articles
• Treatment of idiopathic pulmonary fibrosis: a network meta-analysis  Journal Articles
• Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective  Journal Articles
• Treatment of venous thromboembolic disease.  Journal Articles
• Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study  Journal Articles
• Treatment of venous thromboembolism with dabigatran  Journal Articles
• Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial  Journal Articles
• Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer  Journal Articles
• Treatment with novel oral anticoagulants  Journal Articles
• Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial  Journal Articles
• Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018  Journal Articles
• Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014  Journal Articles
• Tumorkrankheit, Thromboembolien und antithrombotische Therapie: Gibt es ein Antikoagulans der Wahl?  Journal Articles
• Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users  Journal Articles
• Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF  Journal Articles
• Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study  Journal Articles
• Unanswered questions in venous thromboembolism  Journal Articles
• Uncertainty in the minimum event risk to justify treatment was evaluated  Journal Articles
• Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?  Journal Articles
• Underpowered observational studies create confusion regarding clinical impact of surgical interventions  Journal Articles
• Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis  Journal Articles
• Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns  Journal Articles
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Journal Articles
• Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis  Journal Articles
• Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder  Journal Articles
• Unraveling Severe Sepsis  Journal Articles
• Unresolved issues in anticoagulant therapy  Conferences
• Unresolved issues in the use of direct acting oral anticoagulants  Journal Articles
• Unusual presentation of renal vein thrombosis with pulmonary artery embolism  Journal Articles
• Update on heparin: what do we need to know?  Journal Articles
• Update on the Treatment of Venous Thromboembolism  Journal Articles
• Updates in thrombosis in pediatrics: where are we after 20 years?  Journal Articles
• Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry  Journal Articles
• Upstream anticoagulation for patients with ST‐elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial  Journal Articles
• Urgent Need to Measure Effects of Direct Oral Anticoagulants  Journal Articles
• Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial  Journal Articles
• Use and Underuse of Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Old and New Paradigms  Journal Articles
• Use of Alternative Medicines by Patients with OA that Adversely Interact with Commonly Prescribed Medications  Journal Articles
• Use of Anticoagulants during Pregnancy  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions  Journal Articles
• Use of a single anti-Xa calibration curve is adequate for monitoring enoxaparin and tinzaparin levels in children  Journal Articles
• Use of anticoagulants during pregnancy.  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I  Journal Articles
• Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.  Journal Articles
• Use of decision aids for shared decision making in venous thromboembolism: A systematic review  Journal Articles
• Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis  Journal Articles
• Use of genetic data to guide therapy in arterial disease  Journal Articles
• Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol  Journal Articles
• Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients  Journal Articles
• Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease  Journal Articles
• Use of selective factor Xa inhibitors in special populations.  Journal Articles
• Using low molecular weight heparin in special patient populations  Journal Articles
• Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation  Journal Articles
• Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysis  Journal Articles
• VTE Prophylaxis in Critically Ill Adults  Journal Articles
• VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3  Journal Articles
• VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Journal Articles
• Validation of a diagnostic approach to exclude recurrent venous thromboembolism  Journal Articles
• Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.  Journal Articles
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Journal Articles
• Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study  Journal Articles
• Valvular heart disease and pregnancy part II: management of prosthetic valves  Journal Articles
• Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries  Journal Articles
• Variation in bleeding risk estimates among online calculators  Journal Articles
• Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries  Journal Articles
• Vascular viewpoint  Journal Articles
• Vascular viewpoint  Journal Articles
• Vasoflux, a New Anticoagulant With a Novel Mechanism of Action  Journal Articles
• Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis  Journal Articles
• Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158]  Journal Articles
• Venous Thromboembolism Events After Hip Arthroscopy: A Systematic Review  Journal Articles
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update  Journal Articles
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014  Journal Articles
• Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients  Journal Articles
• Venous Thromboembolism and Cancer  Journal Articles
• Venous Thromboembolism and Cancer: Risks and Outcomes  Journal Articles
• Venous Thromboembolism in COVID-19  Journal Articles
• Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials  Journal Articles
• Venous Thromboembolism in Older Adults: A Community-based Study  Journal Articles
• Venous Thromboembolism in Patients with Chronic Obstructive Pulmonary Disease  Journal Articles
• Venous Thromboembolism in the Outpatient Setting  Journal Articles
• Venous and arterial thrombosis in COVID-19: An updated narrative review  Journal Articles
• Venous and arterial thrombosis – pathogenesis and the rationale for anticoagulation  Journal Articles
• Venous gangrene of the extremities.  Journal Articles
• Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome  Journal Articles
• Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin‐induced thrombocytopenia  Journal Articles
• Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors  Journal Articles
• Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE  Journal Articles
• Venous thromboembolism in heparin-induced thrombocytopenia  Journal Articles
• Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada  Journal Articles
• Venous thromboembolism in pregnancy: diagnosis, management and prevention  Journal Articles
• Venous thromboembolism in the elderly  Journal Articles
• Venous thromboembolism management: where do novel anticoagulants fit?  Journal Articles
• Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery  Journal Articles
• Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review  Journal Articles
• Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey  Journal Articles
• Venous thromboembolism: A Call for risk assessment in all hospitalised patients  Journal Articles
• Venous thromboembolism: Past, present and future  Journal Articles
• Venous thromboembolism: diagnosis and management of deep venous thrombosis  Journal Articles
• Venous thromboembolism: diagnosis and management of pulmonary embolism  Journal Articles
• Venous thrombosis  Journal Articles
• Venous thrombosis and hyperhomocysteinaemia  Journal Articles
• Venous thrombosis in children  Journal Articles
• Venous thrombosis in children  Journal Articles
• Venous thrombosis in inflammatory bowel disease  Journal Articles
• Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism  Journal Articles
• Vitamin K Antagonists and Risk of Subdural Hematoma  Journal Articles
• Vitamin K antagonists in heart disease: Current status and perspectives (Section III)  Journal Articles
• Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis  Journal Articles
• Vitamin K for the Treatment of Asymptomatic Coagulopathy Associated with Oral Anticoagulant Therapy  Conferences
• Vitamin K in anticoagulation therapy  Journal Articles
• Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?  Journal Articles
• Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10  Journal Articles
• Voting with your fondaparinux  Journal Articles
• Warfarin After Bioprosthetic Aortic Valve Implantation  Journal Articles
• Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K  Journal Articles
• Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios  Journal Articles
• Warfarin Interactions With Antibiotics in the Ambulatory Care Setting  Journal Articles
• Warfarin Is the Preferred Therapy for Patients With Thrombotic APS  Journal Articles
• Warfarin Maintenance Dosing Patterns in Clinical Practice  Journal Articles
• Warfarin Prophylaxis in the Antiphospholipid Antibody Syndrome  Journal Articles
• Warfarin Therapy for Atrial Fibrillation: The Patient's Preference Is Important  Journal Articles
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Journal Articles
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm  Journal Articles
• Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility  Journal Articles
• Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis  Journal Articles
• Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials  Journal Articles
• Warfarin in Heart Failure  Journal Articles
• Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.  Journal Articles
• Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty  Journal Articles
• Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome  Journal Articles
• Warfarin‐associated multiple digital necrosis complicating heparin‐induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma‐associated thrombotic endocarditis  Journal Articles
• Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden  Journal Articles
• Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more  Journal Articles
• Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery  Journal Articles
• Well-managed warfarin is superior to NOACs Response  Journal Articles
• What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review  Journal Articles
• What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?  Journal Articles
• What Is the Future of Factor XI Inhibitors?  Journal Articles
• What’s New for DVT Prophylaxis for the Medically Ill  Journal Articles
• When Direct Oral Anticoagulants Should Not Be Standard Treatment  Journal Articles
• When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH  Journal Articles
• When guidelines collide  Journal Articles
• When is HIT Really HIT?  Journal Articles
• When is it safe to stop for safety?  Journal Articles
• When the Rubber Meets the Road: Adherence and Persistence with Non–Vitamin K Antagonist Oral Anticoagulants and Old Oral Anticoagulants in the Real World—A Problem or A Myth ?  Journal Articles
• When to prescribe oral anticoagulation for patients with device-detected subclinical atrial fibrillation? Insights from the NOAH-AFNET 6 and ARTESiA trials  Journal Articles
• Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation—And With Which Anticoagulant?  Journal Articles
• Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation?  Journal Articles
• Who Is (Still) Getting HIT?  Journal Articles
• Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass  Journal Articles
• Why Do Patients With Atrial Fibrillation Not Receive Warfarin?  Journal Articles
• Why Is Factor Xa Not a Better Target Than Factor IIa for Therapeutic Inhibition of Coagulation?  Journal Articles
• Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)  Journal Articles
• Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?  Journal Articles
• Withdrawal of warfarin after deep vein thrombosis  Journal Articles
• Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment  Journal Articles
• Women’s values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview study  Journal Articles
• Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review  Journal Articles
• Work‐related effort thrombosis in a millwright: A case report  Journal Articles
• World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update  Journal Articles
• Wound Disruption Following Caesarean Delivery in Women With Class III Obesity: A Retrospective Observational Study  Conferences
• XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America  Journal Articles
• XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation  Journal Articles
• Ximelagatran for Secondary Prevention of Venous Thromboembolism  Journal Articles
• Ximelagatran for the secondary prevention of venous thromboembolism  Journal Articles
• Ximelagatran in the Clinic: Practical Management of Patients  Journal Articles
• Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?  Journal Articles
• Ximelagatran or warfarin in atrial fibrillation?  Journal Articles
• Zinc: An important cofactor in haemostasis and thrombosis  Journal Articles
• [Anticoagulants and other drugs effective against thrombosis].  Journal Articles
• [Antithrombotic treatment of atrial fibrillation].  Journal Articles
• [Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].  Journal Articles
• [Difficulties in obtaining financial support for studies of hemorrhage during treatment with anticoagulants].  Journal Articles
• [Length of treatment in deep venous thrombosis--some comments].  Journal Articles
• [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].  Journal Articles
• [Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].  Journal Articles
• [Prevention of deep vein thrombosis and pulmonary thromboembolism].  Journal Articles
• [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].  Journal Articles
• [Prothromplex in stead of Beriplex P/N as acute antidote against warfarin].  Journal Articles
• [The role of heparinoids in the treatment of vascular diseases].  Journal Articles
• [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].  Journal Articles
• [Use of parenteral anticoagulants in patients with coronary syndrome].  Journal Articles
• [Venous thromboembolism, warfarin and cancer--a well-known connection].  Journal Articles
• γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo  Journal Articles
• “Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome  Journal Articles
• “Therapeutic Range” for Oral Anticoagulant Therapy  Journal Articles